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ABSTRACT 
The foci of this dissertation are the synthesis of analogs for chemical biology 
studies, synthetic chemistry method development (with an emphasis on photochemistry), 
and the application of these methods toward total synthesis.  Chapter 1 outlines the 
synthesis of an array of pheromone analogs that are derivatives of the dideoxy sugar 
ascarylose.  Referred to as ascarosides, such compounds have recently been shown to 
influence important biological processes in the model organism Caenorhabditis elegans.  
C. elegans secretes ascarosides into its environment, where the compounds then act as 
signaling molecules by providing information on factors like population density. 
Chapter 2 describes the biological impact of naturally occurring and synthetic 
ascarosides in C. elegans developmental and reproductive assays.  Chemosensation of 
ascarosides results in downregulation of important signaling pathways, which are 
conserved in higher organisms, and our studies provide data on the effects of these 
processes.  We hypothesize that knowledge gained from these studies can be extrapolated 
to provide insight for similar processes in higher organisms such as humans. 
 In Chapter 3, a photochemical approach to total synthesis of the natural product 
delavayine is discussed.  Alkaloids from the same family have shown biological activity 
via binding to human opioid receptors, which are responsible for producing analgesic and 
antidepressant effects.  The photo-SN1 reaction, a process which produces a triplet phenyl 
cation intermediate, was utilized as a central reaction for initiation of a cascade cyclization 
event en route to delavayine.  
Chapter 4 details the development of a strategy for remote C-H functionalization 
using redox catalysis.  The Tzo directing group was used to effect 1,6- and 1,7-hydrogen 
xii 
 
atom transfers from unactivated aliphatics.  The resulting radicals were then oxidized by 
redox (or photoredox) catalysis to form a carbocation that was ultimately trapped by water 
or methanol.  After loss of a proton, successfully hydroxylated or methoxylated products 
were isolated in moderate yields.  This newly developed method was then applied to a 
concise total synthesis of the powerful antidepressant drug fluoxetine (Prozac®), beginning 
from a more inexpensive and simple starting material than current industrial methods.   
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CHAPTER 1: CHEMICAL GENETIC STUDIES ON CHEMOSENSATION IN 
THE MODEL ORGANISM CAENORHABDITIS ELEGANS, PART I: 
SYNTHESIS OF ASCAROSIDES 
 
1.1 Introduction 
Chemical biology, the utilization of chemical principals to examine biological 
processes, has been referred to as “the ultimate team sport.”1  This interdisciplinary field 
has emerged as a high-impact arena for all those with an interest in molecular biology.  In 
2005 and 2006 respectively, the journals entitled Nature Chemical Biology and ACS 
Chemical Biology were created in order to accommodate the bulk of new research in the 
area.  By recognizing the potential of this field, scientists are developing the means to 
answer questions like, “How do small molecules play a role in complex biological 
processes?”, “What can studying such relationships do to improve our overall 
understanding of chemistry and biology?”, and ultimately, “Can we benefit by applying 
this knowledge to make advances in vital areas such as medicine?”  Taking the first steps 
to resolving such questions has been the driving force for the research presented herein.  
The common nematode Caenorhabditis elegans (Figure 1.1) has been widely used 
to study biological processes in animals for nearly half a century, and has facilitated the 
discovery of many important phenomena including RNA interference and programmed cell 
death.2,3  Recently, it has been found that a series of small molecule pheromones regulates 
a variety of biological processes in C. elegans.  Each of these molecules consists of the 
dideoxy sugar ascarylose linked to a fatty acid-like moiety of varying chain length, degree 
of unsaturation, and terminal functionality.  Gathering information about these structural 
features and how they confer activity will be of the utmost importance in understanding 
the roles of these molecules in C. elegans. We furthermore anticipate that small molecule 
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studies will give insight into various biological processes in C. elegans, many of which are 
of importance in higher organisms.   
 
 
 
 
 
 
Figure 1.1 Caenorhabditis elegans hermaphrodite 
1.2 C. elegans Background 
One of the most important choices facing scientists when exploring the realm of 
chemical biology is the selection of a model organism to study.  In the early 1960s, Sydney 
Brenner sought to find a model organism that met certain criteria for studies of higher level 
biological functions such as development.4  The organism needed to be easy to cultivate 
and manipulate in large numbers, have a short generation time, be easily studied under a 
microscope, and be complex enough to contain differentiated organs and a central nervous 
system.5  Bacteria, though heavily used for molecular biology, did not meet the criterion 
of complexity.  Brenner also stated that the fruit fly Drosophila melanogaster was too 
complex for his intentions, and its nervous system was not yet well-studied.3  Through 
much searching, Brenner eventually identified the small nematode Caenorhabditis 
elegans.  C. elegans can be easily cultivated in a laboratory and has a short generation time 
(2-3 days) and lifespan (2-3 weeks).6  An adult hermaphrodite (Figure 1.1) is approximately 
1 mm in length, contains exactly 959 somatic cells, and has a transparent body which can 
3 
 
be observed via light microscopy.  In the 50 years since Brenner’s seminal studies, the 
entire C. elegans genome has been sequenced, its cell lineage and nervous system have 
been completely reconstructed, and its use of RNA interference in the expression of genes 
has been revealed.6  These discoveries have firmly established the worm’s practicality as a 
model organism.   
It has now been determined that C. elegans senses chemical cues, e.g. pheromones, 
via sensory organs located in its head.7  When the correct pheromones are present, and 
when their antagonists are absent, it is believed that this process results in down regulation 
of pathways such as TGF-β8 and IGF-1.9  Homologous pathways to TGF-β and IGF-1 are 
known to influence growth, metabolism, development, longevity, and stress-resistance in 
higher organisms.7  In 2005, the first structural elucidation and synthesis of a C. elegans 
pheromone took place.10  This initially-discovered pheromone is one of no fewer than 
twelve additional compounds,11,12,13,14 some published as recently as 2012.15  Scheme 1.1 
shows some key pheromones.  Several of these additional compounds are potent inducers 
of dauer formation, and others have activity as sexual attractants (Chapter 2).12  It has also 
been shown that these molecules work synergistically by binding to multiple receptors.13,16 
Scheme 1.1 Important C. elegans pheromone components 
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1.3 C. elegans Ascaroside Pheromones 
To date, each pheromone molecule is a derivative of ascarylose, a dideoxy sugar 
which comprises the backbone of the structure (shown in red, Figure 1.2).   Every 
ascaroside also has a fatty-acid like moiety attached by a glycosidic linkage to C1 of the 
sugar.  Ascarosides can vary by many structural features, as shown in Figure 1.2, and the 
names reflect these variations.  Structures can vary by having  or  (R = H or Me, 
respectively) oxygenation of the side chain, of which is more common and therefore 
left out of the name.  Side chains may also contain α,β-unsaturation, which is denoted with 
a Δ in the name of the compound.  The terminus of the side chain regularly varies and may 
include a carboxyc acid (common, not named), methyl ketone (MK), or para-
aminobenzoic acid (PABA) group attached by amide linkage.  Some ascarosides have been 
found to contain a head group at C4 of the sugar.  The indole carboxyl group (IC) shown 
in Figure 1.2 is the most common head group other than the free hydroxyl.  The systematic 
naming of ascarosides follows these differences in structure and is therefore given as (head 
group-)asc-()(Δ)C(# of carbons in side chain)-(terminal group).   
 
 
 
 
 
 
 
Figure 1.2 General structure of ascarosides 
The key structural features of the ascaroside family addressed by these initial 
analog studies are 1) presence of IC head group, 2) side chain length, 3) degree of 
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unsaturation, 4) functionality at the terminus and 5)  vs  oxygenation of the side 
chain.  Study of activity conferred by specific structural features has produced an SAR for 
C. elegans pheromones dauer-inducing ability and given insight into receptor function.  
Naturally occuring ascarosides were also synthesized and used for study of sperm motility 
in C. elegans.  See Chapter 2 for results of both the analog and sperm motility studies.     
1.4 Results and Discussion 
Analogs of the C. elegans dauer-inducing pheromones have been synthesized in 4-
5 steps from dibenzoyl ascarylose, which was previously synthesized according to a known 
procedure.  Ascaroside head group, side chain length, degree of unsaturation, and 
functionality at the terminus have been varied systematically to produce a series of similar 
compounds.  By screening molecules with only slight structural differences from the 
natural products and from each other, we aimed to determine which structural features 
confer activity.  Scheme 1.2 shows all targeted ascarosides, with boxes around targets 
synthesized by this researcher (a total of 12).  
Scheme 1.2 Ascarosides targeted for synthesis 
The first series of ascarosides produced has structures similar to naturally occurring 
pheromones asc-C7 and asc-ΔC9 (also synthesized in this study), shown in Scheme 1.2. 
The first series of targeted compounds range in chain length from four to nine carbons and 
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maintain the carboxylic acid terminal functionality.  Both the saturated and α,β-unsaturated 
derivatives have been synthesized in 4-5 steps from dibenzoyl ascarylose.  Shown in 
Scheme 1.3, enantioenriched, terminal alkene-bearing alcohols (e.g. the depicted (R)-(-)-
4-Penten-2-ol (for n=1) were successfully attached to dibenzoyl ascarylose via BF3-
promoted glycosylation10 to produce intermediate compounds such as 1.1.  Neighboring 
group participation from the adjacent benzoyl protecting group resulted in selective 
formation of the desired  anomer in moderate yields.   
 
Scheme 1.3 Glycosylation 
Olefin cross metathesis with Grubbs II catalyst and methyl acrylate in refluxing 
CH2Cl2 was used to install a methyl ester terminal functionality.  Intermediate series 1.2, 
shown in Scheme 1.4, was readily produced in good yields from this reliable reaction.  To 
provide saturated analogs 1.3, some of each analog 1.2 was hydrogenated with palladium 
on activated carbon in EtOAc.  Scheme 1.4 depicts this high yielding reaction, which 
produced intermediates 1.3 in good yields.  The methyl esters and benzoyl protecting 
groups of both intermediate series 1.2 and series 1.3 were hydrolyzed with 1M LiOH in t- 
BuOH to produce the final ascaroside analogs asc-ΔC(n+5) and asc-C(n+5) in moderate 
to good yields.13 
The next set of analogs includes the indole carboxyl (IC) moiety of natural 
ascaroside IC-asc-C5, shown in Scheme 1.1.  By creating analogs of IC-asc-C5 that also 
contain a side chain of known activity, we intend to ascertain the significance of the indole 
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functionality.  Therefore, two IC containing analogs (IC-asc-ΔC9 & IC-asc-C6-MK, with 
side chains from asc-ΔC9 & asc-C6-MK respectively) have been synthesized in 5 steps 
each from dibenzoyl ascarylose. 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.4 Completion of first ascaroside series 
For the synthesis of IC-asc-C6-MK (Scheme 1.5), the previously described 
glycosylation method was used, this time with (2R,5R)-2,5-hexanediol to produce alcohol 
intermediate 1.4.  PCC oxidation of 1.4 in CH2Cl2 gave ketone 1.5 in outstanding yield at 
which point the benzoyl protecting groups were removed via 1M LiOH hydrolysis in t-
BuOH to produce naturally occurring ascaroside asc-C6-MK.  At this stage, the indole 
carboxyl head group was to be attached at the equatorial free hydroxyl group.  
Unfortunately, the axial hydroxyl proved to be more reactive, (likely due to gauche 
interaction at the equatorial position) which prevented us from achieving monoacylation at 
8 
 
the desired position.  Instead, diacylation of asc-C6-MK with freshly prepared indole-3-
carbonyl chloride in dry CH2Cl2 afforded 1.6 in high yield.
14  In the last step of the 
synthesis, a difficult monohydrolysis of the C2 indole carboxyl group in intermediate 1.6 
was accomplished to give IC-asc-C6-MK, the target analog.  Aliquots of the reaction in 
progress were subjected to 1H NMR where it was observed that an upfield chemical shift 
of the glycosidic proton at C2 correlated to hydrolysis.  After testing several sets of 
conditions, the slightly more reactive axial indole moiety was cleaved in low yield with 
1M LiOH in i-PrOH at 45oC and purified via HPLC.  The isomer containing the indole 
carboxyl group solely at the axial position was never observed. 
Scheme 1.5 Synthesis of IC-asc-C6-MK 
Synthesis of IC-asc-ΔC9 (Scheme 1.6) commenced with BF3-promoted 
glycosylation with dibenzoyl ascarylose and (R)-(-)-7-Octan-2-ol to yield 1.1 at which 
point the benzoyl groups were hydrolyzed to obtain terminal alkene 1.7.  Diacylation with 
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indole-3-carbonyl chloride yielded 1.8, and methyl ester 1.9 was produced in excellent 
yield using Grubbs II catalyst for olefin cross metathesis with methyl acrylate.  Finally, 
monohydrolysis of the C2 indole carboxyl group (and simultaneous methyl ester cleavage) 
in intermediate 1.9 was accomplished to give target compound IC-asc-ΔC9.  It is 
interesting to note that, while testing conditions for the monohydrolysis of the indole group 
at C2 during the synthesis of IC-asc-C6-MK (Scheme 1.5), it was found that t-BuOH was 
not a suitable solvent.  The reaction did not proceed at room temperature and progressed 
too rapidly at elevated temperature in t-BuOH, and therefore i-PrOH was used as an 
acceptable alternative.  However, for the quite similar transformation of 1.1 to IC-asc-ΔC9 
the same was not true.  In fact, a much improved yield was obtained by using t-BuOH with 
1M LiOH at 50oC.  Again, none of the isomer containing the indole carboxyl solely at the 
axial position was ever observed. 
Scheme 1.6 Synthesis of IC-asc-ΔC9 
10 
 
To further understand the importance of the IC moiety, it was desirable to 
synthesize analogs with a very similar side chain to IC-asc-C5 (Scheme 1.1), but which 
lacked the IC.  One such analog had been previously synthesized (Scheme 1.4, asc-C6).  
This analog was one side-chain carbon longer (6 carbons total) than IC-asc-C5, and 
therefore additional analogs with 4 and 5 carbon side chains were synthesized.  Scheme 
1.7 shows the synthetic pathway beginning with previously accessed intermediates 1.1 
undergoing ozonolysis in CH2Cl2 at -78
oC.  Upon workup with PPh3, the desired aldehyde 
was obtained (unpurified, confirmed by 1H NMR) and subjected to Pinnick oxidation 
conditions to afford carboxylic acid series 1.10.14  Hydrolysis under the customary set of 
conditions successfully generated target analogs asc-C4 and asc-C5. 
 
 
 
 
 
 
Scheme 1.7 Synthesis of asc-C4 and asc-C5 
In some instances, enantiomerically enriched alcohols for glycosylation were not 
commercially available.  Thus, the 7 and 8 carbon chain alcohols, (R)-hept-6-en-2-ol and 
(R)-oct-7-en-2-ol respectively, were synthesized via organocuprate opening of 
commercially available (R)-(+)-propylene oxide as shown in Scheme 1.8.  These reactions 
consistently produced the desired alcohols is high yield. 
11 
 
 
 
Scheme 1.8 Epoxide opening 
1.5 Conclusions 
 Target ascarosides were successfully synthesized in 4-5 steps from dibenzoyl 
ascarylose.  Both the equivalents of alcohol for glycosylation and equivalents of methyl 
acrylate for cross metathesis proved to be important and required significant optimization.  
In most cases, hydrolysis of benzoyl esters proved to be much higher yielding if t-butanol 
was used as solvent rather than methanol.  By far the most challenging synthetic step 
involved placement of the indole carboxyl moiety in two of the analogs.  It was necessary 
to diacylate both compounds due to the higher reactivity of the unwanted axial position.  
Then, removal of the indole group from the axial position proved to be extremely sensitive.  
Even though the two target analogs were very similar in structure, the same set of 
conditions did not work for both.  Instead, careful optimization was required for each 
analog, including monitoring of the reaction by NMR. 
Though many steps were challenging and required careful planning and 
optimization, all were finally accomplished.   Most of the target analogs were quite polar 
and required HPLC purification.  Also, during synthesis of analogs, it was discovered that 
analog target IC-asc-ΔC9 was a natrually occuring ascaroside. 
1.6  Experimental 
Representative procedure for glycosylation: 
A suspension of 1.0228 g (2.8720 mmol) dibenzoylascarylose, 0.54 mL (4.5 mmol) alcohol 
and 325.8 mg 4Å molecular sieves in 32 mL CH2Cl2 was cooled to 0
oC.  To this suspension 
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was added 1.54 mL (12.2 mmol) BF3
.OEt2 at once.  The resulting suspension was stirred 
at 0oC for 7 h.  30 mL saturated NaHCO3 solution was then added.  Upon cessation of 
effervescence, the aqueous layer was separated from the organic layer and then extracted 
with 3 x 20 mL CH2Cl2.  The resulting organic extracts were dried over MgSO4 and filtered 
to obtain 1.5492 mg of oil.  Column chromatography (35 g silica gel, gradient run from 
50% hexanes in CH2Cl2 to 30% hexanes in CH2Cl2) afforded 1.1364 mg (90%) of a 
colorless syrup. 
Synthesis of 1.1, n=1 (glycosylation):   
 
 
 
Began with 234.6 mg dibenzoyl ascarylose, column chromatography (14.5 g silica gel, 
30% hexanes in CH2Cl2) yielded 193.8 mg (69%) of a colorless oil.  [α]D25 = -9.34, c 3.18 
(MeOH);  HRMS (m/z): [M+Na]
+ calcd. for C25H28O6Na 447.1778, found 447.1788; 
 1H 
NMR (400 MHz, CDCl3) δ 8.12 (d, J = 7.4 Hz, 2H), 8.05 (d, J = 7.5 Hz, 2H), 7.63 – 7.54 
(m, 2H), 7.51 – 7.42 (m, 4H), 5.89 (ddt, J = 14.0, 5.1 Hz, 1H), 5.25 – 5.08 (m, 4H), 4.97 
(s, 1H), 4.22 – 4.05 (m, 1H), 3.98 – 3.86 (m, 1H), 2.48 – 2.36 (m, 2H), 2.36 – 2.27 (m, 1H), 
2.21 (ddd, J = 13.9, 11.1, 3.1 Hz, 1H), 1.28 (d, J = 6.1 Hz, 3H), 1.21 (d, J = 6.0 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 165.68, 165.56, 134.81, 133.15, 133.08, 129.94, 129.77, 
129.52, 128.35, 117.13, 93.89, 72.35, 71.09, 70.57, 66.82, 41.53, 29.60, 18.84, 17.73.   
Synthesis of 1.1, n=2 (glycosylation): 
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Began with 750.0 mg dibenzoyl ascarylose, column chromatography (55 g silica gel, 30% 
hexanes in CH2Cl2) yielded 684.1 mg (74%) of a colorless oil.  [α]D25 = 90.0, c 1.01 
(CH2Cl2);  HRMS (m/z): [M+Na]
+ calcd. for C26H30O6Na 461.1935, found 461.1931;
 1H 
NMR (400 MHz, CDCl3) δ 8.12 (d, J = 7.6 Hz, 2H), 8.05 (d, J = 7.6 Hz, 2H), 7.59 (t, J = 
7.2 Hz, 2H), 7.52 – 7.42 (m, 4H), 5.88 (ddt, J = 16.9, 10.2, 6.6 Hz, 1H), 5.25 – 5.13 (m, 
2H), 5.09 (dd, J = 17.1, 2.0 Hz, 1H), 5.02 (d, J = 10.2 Hz, 1H), 4.96 (s, 1H), 4.13 (dq, J = 
12.3, 6.3 Hz, 1H), 3.88 (h, J = 6.2 Hz, 1H), 2.42 (ddd, J = 13.4, 3.9 Hz, 1H), 2.31 – 2.13 
(m, 3H), 1.83 – 1.69 (m, 1H), 1.68 – 1.58 (m, 1H), 1.29 (d, J = 6.3 Hz, 3H), 1.21 (d, J = 
6.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 165.81, 165.69, 138.41, 133.25, 133.19, 
130.01, 129.87, 129.63, 128.45, 114.77, 93.74, 72.01, 71.26, 70.66, 67.03, 36.37, 29.98, 
29.75, 19.11, 17.89. 
Synthesis of 1.1, n=3 (glycosylation):   
 
 
 
Began with 320.5 mg dibenzoyl ascarylose, column chromatography (30.5 g silica gel, 
gradient run from 5% ethyl acetate in hexanes to 10% ethyl acetate in hexanes) yielded 
213.2 mg (52%) of a colorless oil.   [α]D25 = -55.7, c 0.60 (MeOH); HRMS (m/z): [M+Na]+ 
calcd. for C27H32O6Na 475.2091, found 475.2083; 
 1H NMR (250 MHz, CDCl3) δ 8.18 – 
8.08 (m, 2H), 8.08 – 7.98 (m, 2H), 7.66 – 7.53 (m, 2H), 7.53 – 7.39 (m, 4H), 5.86 (ddt, J 
= 16.9, 10.2, 6.6 Hz, 1H), 5.26 – 5.11 (m, 2H), 5.11 – 4.91 (m, 3H), 4.19 – 4.04 (m, 1H), 
3.87 (dq, J = 13.2, 6.9, 6.2 Hz, 1H), 2.42 (dt, J = 13.0, 4.0 Hz, 1H), 2.30 – 2.00 (m, 3H), 
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1.74 – 1.39 (m, 4H), 1.28 (d, J = 6.1 Hz, 3H), 1.20 (d, J = 6.1 Hz, 3H);  13C NMR (101 
MHz, CDCl3) δ 165.78, 165.65, 138.68, 133.21, 133.15, 130.01, 129.86, 129.84, 129.60, 
128.42, 114.58, 93.76, 72.43, 71.24, 70.65, 66.97, 36.54, 33.60, 29.72, 24.95, 19.14, 17.86. 
Synthesis of 1.1, n=4 (glycosylation):   
 
 
 
Began with 486.1 mg dibenzoyl ascarylose, column chromatography (20 g silica gel, 30% 
hexanes in CH2Cl2) yielded 440.0 mg (69%) of a colorless oil.   [α]D25 = 89.4, c 0.085 
(CH2Cl2); HRMS (m/z): [M+Na]
+ calcd. for C28H34O6Na 489.2248, found 489.2250; 
1H 
NMR (250 MHz, CDCl3) δ 8.19 – 8.09 (m, 2H), 8.09 – 7.99 (m, 2H), 7.61 – 7.49 (m, 2H), 
7.51 – 7.37 (m, 4H), 5.85 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H), 5.29 – 5.12 (m, 2H), 5.10 – 4.93 
(m, 3H), 4.15 (dq, J = 12.3, 6.2 Hz, 1H), 3.87 (h, J = 5.9 Hz, 1H), 2.44 (dt, J = 13.4, 4.0 
Hz, 1H), 2.23 (ddd, J = 13.8, 11.3, 3.1 Hz, 1H), 2.11 (d, J = 6.5 Hz, 2H), 1.70 – 1.41 (m, 
6H), 1.31 (d, J = 6.3 Hz, 3H), 1.20 (d, J = 6.0 Hz, 3H);  13C NMR (63 MHz, CDCl3) δ 
165.57, 165.45, 138.64, 133.06, 133.01, 129.89, 129.77, 129.71, 129.50, 129.45, 128.28, 
114.34, 93.62, 72.35, 71.13, 70.53, 66.83, 36.85, 33.65, 29.60, 28.65, 25.10, 19.06, 17.76. 
Synthesis of 1.4 (glycosylation):   
 
 
 
Began with 400.0 mg dibenzoyl ascarylose, column chromatography (50 g silica gel, 
gradient run from 20% EtOAc in hexanes to 100% EtOAc) yielded 297.5 mg (58%) of a 
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colorless oil.   [α]D25 = 3.1, c 1.46 (CH2Cl2); HRMS (m/z): [M+Na]+ calcd. for C26H32O7Na 
479.2040, found 479.2046;  1H NMR (250 MHz, MeOD) δ 8.08 (d, J = 7.3 Hz, 2H), 8.00 
(d, J = 7.7 Hz, 2H), 7.60 (t, J = 6.6 Hz, 2H), 7.56 – 7.40 (m, 4H), 5.21 – 5.03 (m, 2H), 4.96 
(s, 1H), 4.16 (dq, J = 12.5, 6.4 Hz, 1H), 3.93 – 3.70 (m, 2H), 2.39 (dt, J = 13.4, 4.0 Hz, 
1H), 2.19 (ddd, J = 13.9, 11.3, 3.1 Hz, 1H), 1.90 – 1.39 (m, 4H), 1.25 (d, J = 6.2 Hz, 3H), 
1.20 (d, J = 6.1 Hz, 6H);  13C NMR (101 MHz, CDCl3) δ 165.75, 165.62, 133.21, 133.14, 
129.89, 129.80, 129.75, 129.56, 128.39, 93.65, 72.49, 71.15, 70.56, 67.81, 67.02, 35.05, 
33.01, 29.65, 23.57, 19.04, 17.81. 
Representative procedure for cross metathesis: 
To a solution of 40.0 mg (0.0734 mmol) terminal alkene and 33 µL (0.37 mmol) methyl 
acrylate in 4.0 mL CH2Cl2 was added 3.7 mg (0.0044 mmol) Grubbs 2
nd generation 
ruthenium catalyst at once.  The resulting solution was allowed to stir at reflux for 1.5 h.  
The reaction mixture was concentrated to 67.6 mg of brown-red oil.  Column 
chromatography (4 g silica gel, gradient run from pure CH2Cl2 to 15% ethyl acetate in 
CH2Cl2) afforded 42.2 mg (0.0700 mmol ) (95%) of a clear oil. 
Synthesis of 1.2, n=1 (cross metathesis):   
 
 
 
Began with 177.2 mg 1.1, n=1, column chromatography (20.5 g silica gel, gradient run 
from 2% Et2O in hexanes to 10% Et2O in hexanes) yielded 173.6 mg (86%) of a colorless 
oil.  [α]D25 = 75.9, c 1.27 (CH2Cl2);  HRMS (m/z): [M+Na]+ calcd. for C27H30O8Na 
505.1833, found 505.1838;  1H NMR (250 MHz, CDCl3) δ 8.11 (d, J = 7.5 Hz, 2H), 8.04 
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(d, J = 7.8 Hz, 2H), 7.66 – 7.52 (m, 2H), 7.50 – 7.39 (m, 4H), 7.14 – 6.94 (m, 1H), 5.96 (d, 
J = 15.8 Hz, 1H), 5.23 – 5.10 (m, 2H), 4.95 (s, 1H), 4.13 – 3.94 (m, 2H), 3.74 (s, 3H), 2.57 
– 2.34 (m, 3H), 2.17 (t, J = 12.1 Hz, 1H), 1.32 – 1.19 (m, 6H); 13C NMR (101 MHz, CDCl3) 
δ 166.64, 165.73, 165.59, 145.42, 133.25, 133.15, 129.90, 129.81, 129.72, 129.61, 128.41, 
128.39, 123.29, 93.89, 71.47, 70.95, 70.37, 67.06, 51.43, 39.74, 29.58, 19.19, 17.70. 
Synthesis of 1.2, n=2 (cross metathesis):   
 
 
 
Began with 670.0 mg 1.1, n=2, column chromatography (107 g silica gel, gradient run from 
2% Et2O in hexanes to 20% Et2O in hexanes) yielded 630.5 mg (83%) of a colorless oil.  
[α]D25 = 86.4, c 1.03 (CH2Cl2);  HRMS (m/z): [M+Na]+ calcd. for C28H32O8Na 519.1989, 
found 519.1990; 1H NMR (250 MHz, CDCl3) δ 8.11 (d, J = 7.3 Hz, 2H), 8.05 (d, J = 7.4 
Hz, 2H), 7.59 (t, J = 7.0 Hz, 2H), 7.53 – 7.40 (m, 4H), 7.15 – 6.95 (m, 1H), 5.91 (d, J = 
15.7 Hz, 1H), 5.27 – 5.09 (m, 2H), 4.96 (s, 1H), 4.06 (dq, J = 12.8, 6.3 Hz, 1H), 3.88 (h, J 
= 11.8, 6.3 Hz, 1H), 3.73 (s, 3H), 2.51 – 2.29 (m, 3H), 2.19 (ddd, J = 13.9, 10.9, 3.1 Hz, 
1H), 1.90 – 1.61 (m, 2H), 1.28 (d, J = 6.2 Hz, 3H), 1.22 (d, J = 6.1 Hz, 3H); 13C NMR (101 
MHz, CDCl3) δ 167.01, 165.80, 165.68, 148.95, 133.29, 133.22, 129.95, 129.87, 129.81, 
129.65, 128.47, 121.28, 93.73, 71.73, 71.14, 70.56, 67.20, 51.47, 35.36, 29.71, 28.40, 
19.07, 17.87.   
Synthesis of 1.2, n=3 (cross metathesis):   
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Began with 202.0 mg 1.1, n=3, column chromatography (32 g silica gel, gradient run from 
5% EtOAc in hexanes to 15% EtOAc in hexanes) yielded 170.8 mg (75%) of a colorless 
oil.   [α]D25 = -1.3, c 2.22 (MeOH); HRMS (m/z): [M+Na]+ calcd. for C29H34O8Na 
533.2146, found 533.2143;  1H NMR (250 MHz, CDCl3) δ 8.15 – 8.08 (m, 2H), 8.08 – 8.00 
(m, 2H), 7.66 – 7.53 (m, 2H), 7.46 (td, J = 7.4, 6.8, 2.0 Hz, 4H), 7.02 (dt, J = 15.7, 6.9 Hz, 
1H), 5.88 (d, J = 15.7 Hz, 1H), 5.25 – 5.10 (m, 2H), 4.95 (s, 1H), 4.16 – 4.01 (m, 1H), 3.93 
– 3.79 (m, 1H), 3.72 (s, 3H), 2.42 (dt, J = 13.5, 4.0 Hz, 1H), 2.35 – 2.10 (m, 3H), 1.77 – 
1.49 (m, 4H), 1.28 (d, J = 6.2 Hz, 3H), 1.20 (d, J = 6.0 Hz, 3H);  13C NMR (63 MHz, 
CDCl3) δ 167.04, 165.74, 165.63, 149.08, 133.21, 133.14, 129.92, 129.81, 129.59, 128.41, 
121.16, 93.69, 72.20, 71.15, 70.56, 67.05, 51.39, 36.49, 32.05, 29.69, 24.12, 19.08, 17.86. 
Synthesis of 1.2, n=4 (cross metathesis): 
 
 
 
Began with 513.6 mg 1.1, n=4, column chromatography (50 g silica gel, isocratic run of 
100% CH2Cl2) yielded 534.4 mg (93%) of a colorless oil.  [α]D25 = -7.0, c 7.58 (CH2Cl2); 
HRMS (m/z): [M+Na]+ calcd. for C30H36O8Na 547.2302, found 547.2317; 
1H NMR (250 
MHz, CDCl3) δ 8.16–8.09 (m, 2H), 8.09–8.02 (m, 2H), 7.64–7.56 (m, 2H), 7.48 (m, 4H), 
7.01 (dt, J= 15.7, 7.0 Hz, 1H), 5.91–5.81 (m, 1H), 5.25–5.14 (m, 2H), 4.96 (s, 1H), 4.17–
4.05 (m, 1H), 3.85 (t,J= 8.4 Hz, 1H), 3.72 (s, 3H), 2.44 (dt, J= 13.4, 4.0 Hz, 1H), 2.32–2.15 
(m, 3H), 1.60–1.47 (m, 6H), 1.29 (d,J= 6.2 Hz, 3H), 1.21 (d,J= 6.0 Hz, 3H); 13C NMR (101 
MHz, CDCl3) δ 167.17, 165.87, 165.77, 149.43, 133.36, 133.31, 130.10, 129.97, 129.73, 
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128.57, 121.18, 93.91, 72.63, 71.35, 70.76, 67.15, 51.49, 36.97, 32.28, 29.84, 28.09, 25.38, 
19.28, 18.01. 
Synthesis of 1.9 (cross metathesis):  
 
 
 
 
 
Began with 40.0 mg 1.8, column chromatography (5 g silica gel, CH2Cl2, then a gradient 
from 5% EtOAc in CH2Cl2 to 15% EtOAc in CH2Cl2) yielded 42.2 mg (95%) of a white 
solid.  [α]D25 = 53.0, c 0.245 (CH2Cl2); HRMS (m/z): [M+Na]+ calcd. for C34H38N2O8Na 
625.2520, found 625.2544; 1H NMR (400 MHz, CDCl3) δ 9.39 (s, 1H), 9.35 (s, 1H), 8.26 
(d, J = 7.9 Hz, 1H), 8.17 – 8.12 (m, 1H), 7.94 (d, J = 2.7 Hz, 1H), 7.89 (d, J = 2.8 Hz, 1H), 
7.43 – 7.36 (m, 2H), 7.30 – 7.19 (m, 4H), 7.03 (dt, J = 15.6, 6.9 Hz, 1H), 5.88 (d, J = 15.6 
Hz, 1H), 5.32 (ddd, J = 14.4, 9.4, 4.0 Hz, 1H), 5.25 – 5.21 (m, 1H), 5.05 (s, 1H), 4.17 (dq, 
J = 12.2, 6.0 Hz, 1H), 3.91 – 3.85 (m, 1H), 3.72 (s, 3H), 2.56 – 2.49 (m, 1H), 2.32 – 2.24 
(m, 3H), 1.72 – 1.63 (m, 1H), 1.59 – 1.49 (m, 4H), 1.49 – 1.42 (m, 1H), 1.35 (d, J = 6.2 
Hz, 3H), 1.20 (d, J = 6.0 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 167.33, 164.65, 164.33, 
149.63, 136.22, 136.18, 131.86, 131.77, 125.79, 125.70, 123.17, 123.03, 122.10, 122.05, 
121.26, 121.11, 120.91, 111.82, 111.69, 108.10, 107.88, 94.10, 72.25, 70.01, 69.63, 67.35, 
51.44, 36.87, 32.21, 30.12, 27.95, 25.36, 19.15, 18.01. 
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Representative procedure for hydrogenation:   
A suspension of 376.7 mg (0.7377 mmol) unsaturated ester and 44.9 mg 10 % palladium 
on activated carbon in 41 mL EtOAc was vacuum purged and back filled with H2 from a 
balloon.  The resulting suspension was allowed to stir at 23oC for 24 h.  The reaction 
mixture was filtered through Celite® and concentrated to obtain 375.4 mg (99%) of 
colorless oil that required no further purification. 
Synthesis of 1.3, n=1 (hydrogenation):   
 
 
 
Began with 90.4 mg 1.2, n=1, column chromatography (2.5 g silica gel, CH2Cl2) yielded 
66.1 mg (73%) of a colorless oil.   HRMS (m/z): [M+Na]
+ calcd. for C27H32O8Na 507.1989, 
found 507.1990;  1H NMR (250 MHz, CDCl3) δ 8.12 (d, J = 7.2 Hz, 2H), 8.06 (d, J = 7.1 
Hz, 2H), 7.66 – 7.53 (m, 2H), 7.53 – 7.39 (m, 4H), 5.29 – 5.10 (m, 2H), 4.96 (s, 1H), 4.21 
– 4.02 (m, 1H), 3.88 (h, J = 6.0 Hz, 1H), 3.70 (s, 3H), 2.51 – 2.30 (m, 3H), 2.21 (ddd, J = 
13.9, 11.3, 3.1 Hz, 1H), 1.95 – 1.47 (m, 4H), 1.29 (d, J = 6.2 Hz, 3H), 1.22 (d, J = 6.0 Hz, 
3H); 13C NMR (101 MHz, CDCl3) δ 173.89, 165.73, 165.62, 133.20, 133.13, 129.94, 
129.81, 129.59, 128.39, 93.72, 72.12, 71.17, 70.56, 67.05, 51.48, 36.41, 33.90, 29.68, 
21.14, 19.01, 17.82. 
Synthesis of 1.3, n=2 (hydrogenation):   
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Began with 324.0 mg 1.2, n=2, (no purification) yielded 318.4 mg (98%) of a colorless oil.  
[α]D25 = -36.8, c 1.01 (MeOH);  HRMS (m/z): [M+Na]+ calcd. for C28H34O8Na 521.2146, 
found 521.2148 1H NMR (250 MHz, CDCl3) δ 8.11 (d, J = 7.2 Hz, 2H), 8.05 (d, J = 7.3 
Hz, 2H), 7.59 (t, J = 7.3 Hz, 2H), 7.53 – 7.39 (m, 4H), 5.27 – 5.09 (m, 2H), 4.95 (s, 1H), 
4.10 (dq, J = 12.1, 6.4 Hz, 1H), 3.90 – 3.77 (m, 1H), 3.68 (s, 3H), 2.48 – 2.30 (m, 3H), 2.19 
(ddd, J = 13.7, 11.3, 3.1 Hz, 1H), 1.69 (dq, J = 13.6, 7.3, 6.8 Hz, 2H), 1.61 – 1.37 (m, 4H), 
1.28 (d, J = 6.2 Hz, 3H), 1.19 (d, J = 6.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 173.82, 
165.58, 165.49, 133.08, 133.02, 129.87, 129.75, 129.69, 129.47, 128.29, 93.65, 72.26, 
71.10, 70.51, 66.89, 51.30, 36.61, 33.87, 29.58, 25.11, 24.78, 18.98, 17.73. 
Synthesis of 1.3, n=3 (hydrogenation):   
 
 
 
Began with 83.1 mg 1.2, n=3, (no purification necessary) yielded 81.3 mg (98%) of a 
colorless oil.   [α]D25 = -1.1, c 0.355 (MeOH); HRMS (m/z): [M+Na]+ calcd. for 
C29H36O8Na 535.2302, found 535.2305; 
 1H NMR (250 MHz, CDCl3) δ 8.14 – 8.07 (m, 
2H), 8.07 – 7.99 (m, 2H), 7.60 – 7.50 (m, 2H), 7.50 – 7.39 (m, 4H), 5.25 – 5.10 (m, 2H), 
4.95 (s, 1H), 4.18 – 4.03 (m, 1H), 3.91 – 3.76 (m, 1H), 3.64 (s, 3H), 2.42 (dt, J = 13.6, 4.0 
Hz, 1H), 2.33 (t, J = 7.4 Hz, 2H), 2.20 (ddd, J = 13.7, 11.3, 3.1 Hz, 1H), 1.77 – 1.57 (m, 
3H), 1.57 – 1.32 (m, 5H), 1.28 (d, J = 6.2 Hz, 3H), 1.18 (d, J = 6.0 Hz, 3H);  13C NMR (63 
MHz, CDCl3) δ 173.97, 165.61, 165.51, 133.09, 133.03, 129.87, 129.75, 129.71, 129.48, 
128.30, 93.64, 72.39, 71.13, 70.53, 66.87, 51.31, 36.80, 33.87, 29.60, 28.98, 25.28, 24.78, 
19.02, 17.76. 
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Synthesis of 1.3, n=4 (hydrogenation):   
 
 
 
Began with 100.0 mg 1.2, n=4, column chromatography (2.5 g silica gel, CH2Cl2) yielded 
88.5 mg (88%) of a colorless oil.   [α]D25 = 35.5, c 0.80 (CH2Cl2); HRMS (m/z): [M+Na]+ 
calcd. for C30H38O8Na 549.2459, found 549.2475; 
 1H NMR (250 MHz, CDCl3) δ 8.11 (d, 
J = 7.1 Hz, 2H), 8.04 (d, J = 7.1 Hz, 2H), 7.65 – 7.51 (m, 2H), 7.51 – 7.38 (m, 4H), 5.24 – 
5.06 (m, 2H), 4.95 (s, 1H), 4.11 (dq, J = 12.5, 6.2 Hz, 1H), 3.84 (q, J = 5.9 Hz, 1H), 3.65 
(s, 3H), 2.42 (dt, J = 13.4, 4.0 Hz, 1H), 2.32 (t, J = 7.4 Hz, 2H), 2.27 – 2.11 (m, 1H), 1.74 
– 1.32 (m, 10H), 1.28 (d, J = 6.2 Hz, 3H), 1.18 (d, J = 6.0 Hz, 3H); 13C NMR (101 MHz, 
CDCl3) δ 174.17, 165.75, 165.63, 133.19, 133.13, 129.99, 129.84, 129.82, 129.57, 128.40, 
93.76, 72.58, 71.23, 70.65, 66.93, 51.42, 37.04, 34.04, 29.70, 29.22, 29.10, 25.53, 24.89, 
19.12, 17.84. 
Representative procedure for hydrolysis: 
To a suspension of 141.3 mg (0.2756 mmol) methyl ester in 20 mL tBuOH was added 20 
mL 1M LiOH at once.  The resulting solution was allowed to stir at 23oC for 24 h. 10 mL 
20% iPrOH in CH2Cl2 was added to the reaction mixture, and the layers were separated. 
The aqueous layer was extracted with an additional 5x 10 mL 20% iPrOH in CH2Cl2.  Solid 
NaCl was then added to the aqueous layer until saturation was obtained, and was further 
extracted with 3 x 10 mL 20% iPrOH in CH2Cl2.  The combined organic layers were dried 
over Na2SO4 and filtered.  Evaporation of solvent afforded 117.2 mg of an oil.  Column 
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chromatography (47 g silica gel, gradient run from 5% iPrOH in CH2Cl2 to 20% iPrOH in 
CH2Cl2) afforded 78.9 mg (94%) of a colorless oil. 
Synthesis of asc-ΔC6 (hydrolysis):   
 
 
 
Began with 17.6 mg 1.2, n=1, HPLC purification yielded 5.5 mg (58%) of a colorless oil.   
[α]D25 = -59.5, c 0.82 (MeOH); HRMS (m/z): [M-H]- calcd. for C12H19O6 259.1187, found 
259.1181 1H NMR (400 MHz, CD3OD) δ 6.82 (dt, J = 15.0, 7.3 Hz, 1H), 5.87 (d, J = 15.6 
Hz, 1H), 4.64 (s, 1H), 3.90 (h, J = 6.1 Hz, 1H), 3.72 (s, 1H), 3.68 – 3.56 (m, 1H), 3.47 (td, 
J = 10.7, 9.8, 4.6 Hz, 1H), 2.48 – 2.31 (m, 2H), 1.93 (dt, J = 13.1, 4.0 Hz, 1H), 1.77 (ddd, 
J = 13.3, 11.4, 3.1 Hz, 1H), 1.20 (d, J = 6.2 Hz, 3H), 1.15 (d, J = 6.1 Hz, 3H); 13C NMR 
(101 MHz, CD3OD) δ 170.79, 146.60, 125.71, 98.08, 72.42, 71.44, 69.91, 68.39, 40.81, 
35.92, 19.51, 18.15. 
Synthesis of asc-C6 (hydrolysis):   
 
 
 
Began with 35.0 mg 1.3, n=1, HPLC purification yielded 13.3 mg (70%) of a colorless oil.   
[α]D25 = -74.9, c 0.81 (MeOH); HRMS (m/z): [M-H]- calcd. for C12H21O6 261.1344, found 
261.1342;  1H NMR (400 MHz, CD3OD) δ 4.64 (s, 1H), 3.79 (d, J = 6.1 Hz, 1H), 3.71 (td, 
J = 3.1, 1.4 Hz, 1H), 3.62 (dq, J = 9.4, 6.2 Hz, 1H), 3.50 (ddd, J = 11.1, 9.3, 4.5 Hz, 1H), 
2.34 – 2.25 (m, 2H), 1.94 (dt, J = 13.1, 3.7 Hz, 2H), 1.82 – 1.70 (m, 2H), 1.70 – 1.45 (m, 
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2H), 1.21 (d, J = 6.2 Hz, 3H), 1.12 (d, J = 6.1 Hz, 3H); 13C NMR (101 MHz, CD3OD) δ 
174.92, 94.54, 69.23, 68.29, 67.00, 65.42, 34.81, 33.00, 32.23, 19.58, 16.29, 15.14. 
Synthesis of asc-ΔC7 (hydrolysis):   
 
 
 
Began with 258.1 mg 1.2, n=2 , column chromatography (32 g silica gel, gradient run from 
5% iPrOH in CH2Cl2 to from 50% iPrOH in CH2Cl2, then 10% 1:1:1 H2O:CH3CN:MeOH 
in ethyl acetate) yielded 83.3 mg (58%) of a colorless oil.   [α]D25 = -77.0, c 2.39 (MeOH); 
HRMS (m/z): [M+Na]+ calcd. for C13H22O6Na 297.1309, found 297.1302; 
 1H NMR (400 
MHz, CD3OD) δ 6.97 (dt, J = 15.5, 6.8 Hz, 1H), 5.83 (d, J = 15.6 Hz, 1H), 4.65 (s, 1H), 
3.86 – 3.77 (m, 1H), 3.72 (d, J = 3.7 Hz, 1H), 3.66 – 3.54 (m, 1H), 3.51 (td, J = 10.1, 9.3, 
4.6 Hz, 1H), 2.44 – 2.25 (m, 2H), 1.95 (dt, J = 12.8, 4.0 Hz, 1H), 1.76 (ddd, J = 17.2, 8.7, 
3.4 Hz, 1H), 1.73 – 1.59 (m, 2H), 1.21 (d, J = 6.0 Hz, 3H), 1.15 (d, J = 6.0 Hz, 3H);  13C 
NMR (101 MHz, CD3OD) δ 170.42, 150.66, 123.06, 97.49, 71.72, 71.41, 70.02, 68.44, 
36.86, 36.08, 29.51, 19.29, 18.24. 
Synthesis of asc-C7 (hydrolysis):   
 
 
 
 
Began with 279.5 mg 1.3, n=2, column chromatography (32 g silica gel, gradient run from 
2% iPrOH in CH2Cl2 to 50% iPrOH in CH2Cl2)  yielded 80.0 mg (52%) of a colorless oil.   
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[α]D25 = -90.9, c 1.06 (MeOH); HRMS (m/z): [M+Na]+ calcd. for C13H24O6Na 299.1465, 
found 299.1472;  1H NMR (400 MHz, CD3OD) δ 4.63 (s, 1H), 3.82 – 3.73 (m, 1H), 3.71 
(s, 1H), 3.67 – 3.56 (m, 1H), 3.56 – 3.45 (m, 1H), 2.29 (t, J = 7.4 Hz, 2H), 1.94 (dt, J = 
13.0, 3.8 Hz, 1H), 1.75 (ddd, J = 13.4, 11.3, 3.1 Hz, 1H), 1.68 – 1.35 (m, 6H), 1.21 (d, J = 
6.1 Hz, 3H), 1.11 (d, J = 6.1 Hz, 3H);  13C NMR (101 MHz, CD3OD) δ 177.88, 97.63, 
72.44, 71.30, 70.08, 68.48, 38.17, 36.08, 35.15, 26.52, 26.21, 19.45, 18.22. 
Synthesis of asc-ΔC8 (hydrolysis):   
 
 
 
Began with 63.5 mg 1.2, n=3, HPLC purification yielded 26.7 mg (75%) of a colorless oil.   
[α]D25 = -60.2, c 0.165 (MeOH); HRMS (m/z): [M+Na]+ calcd. for C14H24O6Na 311.1465, 
found 311.1469;  1H NMR (400 MHz, CD3OD) δ 6.94 (dt, J = 14.7, 6.9 Hz, 1H), 5.81 (d, 
J = 15.6 Hz, 1H), 4.64 (s, 1H), 3.79 (q, J = 5.8 Hz, 1H), 3.71 (s, 1H), 3.66 – 3.56 (m, 1H), 
3.51 (td, J = 10.2, 4.2 Hz, 1H), 2.30 – 2.18 (m, 2H), 1.94 (dt, J = 13.2, 3.8 Hz, 1H), 1.81 – 
1.69 (m, 1H), 1.68 – 1.43 (m, 4H), 1.21 (d, J = 6.1 Hz, 3H), 1.12 (d, J = 6.0 Hz, 3H);  13C 
NMR (101 MHz, CD3OD) δ 170.27, 150.91, 122.94, 97.65, 72.39, 71.36, 70.05, 68.45, 
37.94, 36.07, 33.15, 25.57, 19.46, 18.26. 
Synthesis of asc-C8 (hydrolysis):  
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Began with 68.0 mg 1.3, n=3, HPLC purification yielded 25.2 mg (65%) of a colorless oil.   
[α]D25 = -81.5, c 0.955 (MeOH); HRMS (m/z): [M+Na]+ calcd. for C14H26O6Na 313.1622, 
found 313.1627;  1H NMR (250 MHz, CD3OD) δ 4.63 (s, 1H), 3.81 – 3.66 (m, 2H), 3.66 – 
3.44 (m, 2H), 2.28 (t, J = 7.4 Hz, 2H), 1.94 (dt, J = 13.0, 3.9 Hz, 1H), 1.75 (ddd, J = 13.3, 
11.0, 3.0 Hz, 1H), 1.68 – 1.31 (m, 8H), 1.21 (d, J = 6.0 Hz, 3H), 1.11 (d, J = 6.0 Hz, 3H);  
13C NMR (63 MHz, CD3OD) δ 177.83, 97.61, 72.53, 71.27, 70.07, 68.47, 38.35, 36.07, 
35.13, 30.33, 26.70, 26.18, 19.47, 18.23. 
Synthesis of asc-ΔC9 (hydrolysis):   
 
 
 
Began with 98.5 mg 1.2, n=4, HPLC purification yielded 40.9 mg (72%) of a colorless oil.   
[α]D25 = -61.0, c 0.53 (MeOH); HRMS (m/z): [M+Na]+ calcd. for C15H26O6Na 325.1622, 
found 325.1633;  1H NMR (400 MHz, CD3OD) δ 6.93 (dt, J = 14.2, 6.8 Hz, 1H), 5.80 (d, 
J = 15.8 Hz, 1H), 4.63 (s, 1H), 3.84 – 3.73 (m, 1H), 3.71 (s, 1H), 3.61 (dq, J = 11.3, 5.7, 
5.3 Hz, 1H), 3.51 (td, J = 10.2, 9.5, 4.5 Hz, 1H), 2.23 (q, J = 6.5 Hz, 2H), 1.94 (dt, J = 12.9, 
4.0 Hz, 1H), 1.81 – 1.69 (m, 1H), 1.62 – 1.37 (m, 6H), 1.20 (d, J = 6.1 Hz, 3H), 1.11 (d, J 
= 6.1 Hz, 3H);  13C NMR (101 MHz, CD3OD) δ 170.55, 150.86, 123.04, 97.69, 72.54, 
71.35, 70.10, 68.56, 68.47, 38.21, 36.09, 33.21, 29.31, 26.57, 19.49, 18.26. 
Synthesis of asc-C9 (hydrolysis):   
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Began with 70.0 mg 1.3, n=4, column chromatography (30 g silica gel, gradient run from 
50% ethyl acetate in CH2Cl2 to 100% ethyl acetate, then from 2% 1:1:1 
H2O:CH3CN:MeOH in ethyl acetate to 10% 1:1:1 H2O:CH3CN:MeOH in ethyl acetate) 
yielded 20.5 mg (51%) of a colorless oil.   [α]D25 = -58.4, c 0.23 (MeOH); HRMS (m/z): 
[M+Na]+ calcd. for C15H28O6Na 327.1778, found 327.1778; 
 1H NMR (400 MHz, CD3OD) 
δ 4.63 (s, 1H), 3.81 – 3.73 (m, 1H), 3.71 (s, 1H), 3.62 (dq, J = 11.7, 6.0 Hz, 1H), 3.50 (td, 
J = 10.4, 9.6, 4.6 Hz, 1H), 2.27 (t, J = 7.2 Hz, 2H), 1.94 (dt, J = 12.8, 4.0 Hz, 1H), 1.81 – 
1.70 (m, 1H), 1.65 – 1.29 (m, 10H), 1.20 (d, J = 6.2 Hz, 3H), 1.11 (d, J = 6.0 Hz, 3H);  13C 
NMR (101 MHz, CD3OD) δ 178.19, 97.70, 72.67, 71.32, 70.11, 68.49, 38.47, 36.09, 35.38, 
30.53, 30.36, 26.87, 26.34, 19.50, 18.24. 
Synthesis of asc-C4 (hydrolysis):  
 
 
 
Began with 35.7 mg 1.10, n=1, HPLC purification yielded 8.0 mg (42%) of a colorless oil.  
[α]D25 = -98.8, c 0.25 (CH2Cl2); HRMS (m/z): [M+Na]+ calcd. for C10H18O6Na 257.0996, 
found 257.1006; 1H NMR (250 MHz, CD3OD) δ 4.65 (s, 1H), 4.24 (h, J = 6.0 Hz, 1H), 
3.76 – 3.55 (m, 2H), 3.48 (td, J = 10.4, 9.7, 4.6 Hz, 1H), 2.60 – 2.33 (m, 2H), 1.92 (dt, J = 
13.1, 3.9 Hz, 1H), 1.74 (ddd, J = 13.2, 11.2, 3.0 Hz, 1H), 1.21 (d, J = 2.5 Hz, 3H), 1.18 (d, 
J = 2.6 Hz, 3H); 13C NMR (126 MHz, CD3OD) δ 175.88, 97.54, 71.28, 70.02, 70.00, 68.47, 
43.97, 35.99, 19.35, 18.16.    
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Synthesis of asc-C5 (hydrolysis): 
 
 
 
Began with 20.6 mg 1.10, n=2, HPLC purification yielded 8.8 mg (79%) of a colorless oil.  
[α]D25 = -62.2, c 0.51 (MeOH); HRMS (m/z): [M+Na]+ calcd. for C11H20O6Na 271.1152, 
found 271.1150; 1H NMR (250 MHz, CD3OD) δ 4.64 (s, 1H), 3.93-3.75 (m, 1H), 3.71 (q, 
J = 2.7 1H), 3.68-3.41 (m, 2H), 2.41 (t, J = 7.4, 2H), 1.95 (dt, J = 13.1, 3.9 Hz, 1H), 1.87-
1.67 (m, 3H), 1.21 (d, J = 2.5 Hz, 3H), 1.14 (d, J = 6.0 Hz, 3H). 
Synthesis of 1.7 (hydrolysis):   
 
 
 
Began with 20.6 mg 1.1, n=4, HPLC purification yielded 10.7 mg (69%) of a colorless oil.   
[α]D25 = 76.8, c 0.09 (MeOH); HRMS (m/z): [M+Na]+ calcd. for C14H26O4Na 281.1723, 
found 281.1732; 1H NMR (250 MHz, CD3OD) δ 5.81 (ddt, J = 17.0, 10.2, 6.8 Hz, 1H), 
5.06 – 4.88 (m, 2H), 4.63 (s, 1H), 3.81 – 3.67 (m, 2H), 3.67 – 3.44 (m, 2H), 2.06 (q, J = 
5.9, 5.4 Hz, 2H), 1.94 (dt, J = 13.0, 4.0 Hz, 1H), 1.75 (ddd, J = 13.3, 10.9, 3.0 Hz, 1H), 
1.59 – 1.33 (m, 6H), 1.20 (d, J = 6.0 Hz, 3H), 1.11 (d, J = 6.1 Hz, 3H);  13C NMR (63 MHz, 
CD3OD) δ 139.94, 114.87, 97.57, 72.47, 71.15, 69.95, 68.30, 38.21, 35.94, 34.83, 30.02, 
26.35, 19.37, 18.10. 
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Synthesis of asc-C6-MK (hydrolysis):   
 
 
 
Began with 210.0 mg 1.5, HPLC purification yielded 88.9 mg (78%) of a colorless oil.   
[α]D25 = -138.5, c 0.895 (MeOH); HRMS (m/z): [M+Na]+ calcd. for C12H22O5Na 269.1359, 
found 269.1355; 1H NMR (400 MHz, CD3OD) δ 4.63 (s, 1H), 3.78 (ddd, J = 8.0, 6.3, 4.7 
Hz, 1H), 3.70 (td, J = 3.1, 1.5 Hz, 1H), 3.59 – 3.47 (m, 2H), 2.61 (t, J = 7.4 Hz, 2H), 2.15 
(s, 3H), 1.94 (dt, J = 12.9, 3.6 Hz, 1H), 1.81 – 1.66 (m, 3H), 1.21 (d, J = 5.6 Hz, 3H), 1.12 
(d, J = 6.1 Hz, 3H);  13C NMR (101 MHz, CD3OD) δ 211.77, 97.39, 71.63, 71.40, 69.94, 
68.38, 40.58, 36.04, 32.20, 30.02, 19.22, 18.20. 
Representative procedure for ozonolysis and Pinnick oxidation: 
To a solution of 220.0 mg (0.512 mmol) terminal alkene in 80 mL dichloromethane was 
added a stream of O3 at -78
oC.  After 4 min the solution turned a bright blue color, at which 
time the flow of O3 was ceased.  O2 was then allowed to bubble through the mixture for an 
additional 4 minutes until the blue color had completely disappeared, and 518.7 mg Janda 
Jel™ polymer-supported PPh3 (~1.555 mmol phosphine) was then added.   The reaction 
mixture was then allowed to warm to 23oC and stir for 16h under an atmosphere of 
nitrogen.  50 mL H2O was then added and the layers were separated.  The aqueous layer 
was then extracted with 2 x 50 mL dichloromethane, and the organic layers were combined, 
dried over anhydrous Na2SO4 and filtered.  Evaporation of volatiles afforded 240.0 mg of 
an oil (desired aldehyde confirmed with 1H NMR) that was redissolved in 10 mL tBuOH 
and 2.5 mL dimethyl sulfoxide.  To this mixture was added dropwise a solution of 440.2 
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mg (4.867 mmol) 80% NaClO2 and 599.4 mg (3.842 mmol) NaH2PO4·H2O in 4.5 mL H2O 
over the course of 2 min.  The resulting solution was stirred at 23oC for 90 min after which 
the volatiles were evaporated in vacuo.  The crude mixture was then suspended in 20 mL 
H2O, and the pH was adjusted to 3 via the dropwise addition of 1N HCl.  25 mL EtOAc 
was then added and the layers were separated.  The aqueous layer was then extracted with 
3 x 25 mL EtOAc and the organic layers were combined, dried over anhydrous Na2SO4 
and filtered.  Evaporation of volatiles afforded 390 mg of an oil.  Column chromatography 
of the oil afforded 190 mg of a residue that was suspended in 30 mL hexanes and filtered 
in order to remove contaminant dimethyl sulfone.  Evaporation afforded 85.8 mg (38 %, 2 
steps) of a colorless oil.   
Synthesis of 1.10, n=1 (ozonolysis and Pinnick oxidation):  
 
 
 
Began with 220.0 mg 1.1, n=1, column chromatography (35 g silica gel, gradient run from 
100% CH2Cl2 to 25% EtOAc in CH2Cl2) followed by filtration and evaporation afforded 
85.8 mg (38%, 2 steps) of a colorless oil.  [α]D25 = 12.5, c 0.815 (CH2Cl2); HRMS (m/z): 
[M+Na]+ calcd. for C24H26O8Na 465.1520, found 465.1535; 
1H NMR (500 MHz, CDCl3) 
δ 9.61 (s, br, 1H), 8.11 (d, J = 7.8 Hz, 2H), 8.04 (d, J = 7.7 Hz, 2H), 7.63 – 7.53 (m, 2H), 
7.49 – 7.41 (m, 4H), 5.17 (td, J = 10.6, 4.6 Hz, 1H), 5.11 (s, 1H), 4.98 (s, 1H), 4.35 (h, J = 
5.3 Hz, 1H), 4.15 (dq, J = 12.0, 6.2 Hz, 1H), 2.70 (dd, J = 15.5, 8.1 Hz, 1H), 2.52 (dd, J = 
15.5, 5.0 Hz, 1H), 2.39 (dt, J = 13.4, 3.9 Hz, 1H), 2.16 (ddd, J = 13.9, 11.3, 3.1 Hz, 1H), 
1.28 (d, J = 2.5 Hz, 3H), 1.26 (d, J = 2.4 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 177.25, 
30 
 
165.70, 165.60, 133.25, 133.15, 129.88, 129.80, 129.67, 129.57, 128.40, 128.38, 93.48, 
70.90, 70.44, 68.88, 67.09, 42.10, 29.52, 18.96, 17.63. 
Synthesis of 1.10, n=2 (ozonolysis and Pinnick oxidation): 
 
 
 
Began with 300.0 mg 1.1, n=2, column chromatography (10 g silica gel, gradient run from 
100% CH2Cl2 to 10% EtOAC in CH2Cl2) followed by filtration and evaporation afforded 
51.2 mg (16%, 2 steps) of a colorless oil.  [α]D25 = -8.6, c 1.105 (CH2Cl2); HRMS (m/z): 
[M+Na]+ calcd. for C25H28O8Na 479.1676, found 479.1670; 
1H NMR (250 MHz, CDCl3) 
δ 8.17-7.99 (m, 4H), 7.66-7.52 (m, 2H), 7.52-7.38 (m, 4H), 5.24-5.09 (m, 2H), 4.96 (s, 
1H), 4.19-4.01 (m, 1H), 3.93 (h, J = 5.9 Hz, 1H), 2.55 (t, J = 7.4 Hz, 2H), 2.42 (dt, J = 
13.6, 3.9 Hz, 1H), 2.18 (ddd, J = 13.9, 11.3, 3.2 Hz, 1H), 1.92 (q, J = 7.1 Hz, 2H), 1.28 (d, 
J = 6.1 Hz, 3H), 1.22 (d, J = 6.0 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 179.10, 165.90, 
165.80, 133.40, 133.31, 130.01, 129.97, 129.87, 129.77, 128.57, 128.55, 93.60, 71.25, 
71.20, 70.59, 67.32, 31.87, 30.30, 29.79, 18.94, 17.92. 
Synthesis of 1.5 (PCC oxidation):   
 
 
 
To a suspension of 400.0 mg (1.856 mmol) pyridinium chlorochromate and 340.0 mg 4Å 
molecular sieves in 12 mL CH2Cl2 at 0
oC was added 220.0 mg (0.4819 mmol) 1.4 at once.  
The resulting suspension was allowed to stir at 0oC for 2 h. The reaction mixture was 
31 
 
concentrated to 250 mg of dark red oil.  Column chromatography (8 g silica gel, 5% diethyl 
ether in CH2Cl2) afforded 210.0 mg (96%) of a colorless oil.  [α]D25 = 16.8, c 0.495 
(CH2Cl2); HRMS (m/z): [M+Na]
+ calcd. for C26H30O7Na 477.1884, found 477.1905; 
 1H 
NMR (400 MHz, CDCl3) δ 8.09 (d, J = 7.4 Hz, 2H), 8.03 (d, J = 7.5 Hz, 2H), 7.58 – 7.52 
(m, 2H), 7.47 – 7.40 (m, 4H), 5.21 – 5.10 (m, 2H), 4.93 (s, 1H), 4.06 (dq, J = 9.7, 6.3 Hz, 
1H), 3.87 (h, J = 5.8 Hz, 1H), 2.58 (t, J = 7.4 Hz, 2H), 2.41 (dt, J = 13.3, 3.8 Hz, 1H), 2.21 
– 2.13 (m, 4H), 1.85 (q, J = 7.6 Hz, 2H), 1.28 (d, J = 6.2 Hz, 3H), 1.19 (d, J = 6.1 Hz, 3H);  
13C NMR (101 MHz, CDCl3) δ 208.11, 165.55, 165.44, 133.10, 133.04, 129.76, 129.66, 
129.61, 129.43, 128.28, 93.40, 71.29, 70.92, 70.39, 66.96, 39.46, 30.67, 29.75, 29.51, 
18.72, 17.71. 
Representative procedure for diacylation: 
To a solution of 43.5 mg (0.1766 mmol) diol and 250 μL (1.413 mmol) N,N-
Diisopropylethylamine in 12.5 mL THF at 0 oC was added a solution of 190.3 mg (1.060 
mmol) indole-3-carbonyl chloride in 1.5 mL THF dropwise over 3 minutes.  The resulting 
solution was allowed to warm to 23 oC and stir for 6 h.  During this time close monitoring 
of the reaction by TLC showed formation and disappearance of an intermediate, likely the 
monoacylated product at the axial position, followed by appearance of the desired product.  
15 mL of H2O was then added at once and the mixture was allowed to stir for an additional 
30 minutes. 15 mL EtOAc was then added and the layers were separated.  The aqueous 
layer was extracted with an additional 3 x 15 mL EtOAc.  The combined organic layers 
were dried over Na2SO4, filtered and concentrated to a light orange oil.  HPLC purification 
afforded 83.6 mg (89%) of a white solid. 
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Synthesis of 1.6 (diacylation): 
                                                
 
 
 
 
 
Began with 43.5 mg asc-C6-MK, HPLC purification afforded 83.6 mg (89%) of a white 
solid.  [α]D25 = 37.0, c 1.44 (CH2Cl2); HRMS (m/z): [M+Na]+ calcd. for C30H32N2O7Na 
555.2102, found 555.2126; 1H NMR (400 MHz, CDCl3) δ 9.54 (s, 1H), 9.51 (s, 1H), 8.24 
(d, J = 7.9 Hz, 1H), 8.14 (d, J = 7.3 Hz, 1H), 7.88 (d, J = 3.0 Hz, 1H), 7.85 (d, J = 3.1 Hz, 
1H), 7.40 – 7.34 (m, 2H), 7.27 – 7.15 (m, 4H), 5.32 (td, J = 10.4, 4.5 Hz, 1H), 5.21 (s, 1H), 
5.02 (s, 1H), 4.13 (dq, J = 12.2, 6.0 Hz, 1H), 3.91 (h, J = 6.0 Hz, 1H), 2.63 (t, J = 7.4 Hz, 
2H), 2.51 (dt, J = 13.3, 3.7 Hz, 1H), 2.29 – 2.23 (m, 1H), 2.21 (s, 3H), 1.89 (q, J = 7.3 Hz, 
2H), 1.34 (d, J = 6.3 Hz, 3H), 1.19 (d, J = 6.1 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 
209.09, 164.73, 164.39, 136.26, 136.23, 131.96, 131.82, 125.76, 125.67, 123.16, 123.04, 
122.10, 122.05, 121.17, 121.06, 111.87, 111.77, 107.96, 107.72, 93.98, 71.30, 69.94, 
69.62, 67.51, 39.67, 30.84, 30.11, 29.90, 18.82, 17.98. 
Synthesis of 1.8 (diacylation):  
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Began with 43.8 mg 1.7, HPLC purification yielded 40.0 mg (43%) of a colorless oil.   
[α]D25 = 43.0, c 0.40 (CH2Cl2); HRMS (m/z): [M+Na]+ calcd. for C32H36N2O6Na 567.2466, 
found 567.2474; 1H NMR (400 MHz, CDCl3) δ 9.19 (s, 1H), 9.16 (s, 1H), 8.25 (d, J = 7.8 
Hz, 1H), 8.13 (d, J = 7.1 Hz, 1H), 7.91 – 7.88 (m, 1H), 7.88 – 7.83 (m, 1H), 7.41 – 7.32 
(m, 2H), 7.28 – 7.16 (m, 4H), 5.85 (ddt, J = 16.9, 10.2, 6.5 Hz, 1H), 5.33 (td, J = 10.6, 4.6 
Hz, 1H), 5.22 (s, 1H), 5.06 – 4.93 (m, 3H), 4.20 (dq, J = 10.8, 5.5, 5.0 Hz, 1H), 3.88 (h, J 
= 5.9 Hz, 1H), 2.51 (dt, J = 13.6, 4.0 Hz, 1H), 2.34 – 2.22 (m, 1H), 2.15 – 2.07 (m, 2H), 
1.58 – 1.40 (m, 6H), 1.35 (d, J = 5.9 Hz, 3H), 1.19 (d, J = 5.8 Hz, 3H); 13C NMR (101 
MHz, CDCl3) δ 164.65, 164.35, 139.01, 136.29, 136.27, 131.85, 131.57, 126.02, 125.83, 
123.44, 123.28, 122.34, 122.32, 121.60, 121.48, 114.59, 111.82, 111.71, 108.71, 108.40, 
94.34, 72.54, 70.24, 69.84, 67.46, 37.19, 33.97, 30.33, 28.98, 25.49, 19.39, 18.17. 
Synthesis of IC-asc-C6-MK: 
 
 
 
To a solution of 10.2 mg (0.0193 mmol) 1.6 in 3.0 mL i-PrOH at 23 oC was added 3.0 mL 
1M LiOH at once.  The resulting mixture was heated to 45 oC and allowed to stir for 6.5 h.  
The reaction was then permitted to cool to 23 oC at which time 5 mL 20% i-PrOH in CH2Cl2 
was added and the layers were separated.  The aqueous layer was extracted with an 
additional 2 x 5 mL 20% i-propanol in CH2Cl2.  Solid NaCl was then added to the aqueous 
layer until saturation was obtained, and it was further extracted with 2 x 5 mL 20% iPrOH 
in CH2Cl2.  The combined organic layers were dried over Na2SO4, filtered and concentrated 
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to yield 15.4 mg of an oil.  HPLC purification afforded 2.6 mg (35%) of a colorless oil.  
[α]D25 = -12.8, c 0.13 (CH2Cl2); HRMS (m/z): [M+Na]+ calcd. for C21H27NO6Na 412.1731, 
found 412.1735; 1H NMR (250 MHz, CDCl3) δ 8.61 (s, 1H), 8.18 – 8.12 (m, 1H), 7.95 (d, 
J = 3.1 Hz, 1H), 7.46 – 7.40 (m, 1H), 7.33 – 7.28 (m, 2H), 5.18 – 5.06 (m, 1H), 4.77 (s, 
1H), 4.08 – 3.98 (m, 1H), 3.92 – 3.84 (m, 2H), 2.62 (t, J = 7.5 Hz, 2H), 2.34 – 2.17 (m, 
4H), 2.13 – 1.99 (m, 1H), 1.93 – 1.79 (m, 2H), 1.29 (d, J = 6.3 Hz, 3H), 1.19 (d, J = 6.1 
Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 208.52, 162.30, 136.09, 131.27, 125.75, 123.37, 
122.21, 121.49, 111.58, 108.83, 96.22, 70.98, 69.38, 68.79, 68.01, 39.75, 32.31, 30.94, 
29.99, 18.96, 17.76. 
Synthesis of IC-asc-ΔC9:  
                                                
To a solution of 10.2 mg (0.0169 mmol) 1.9 in 2.5 mL t-BuOH at 23 oC was added 2.5 mL 
1M LiOH at once.  The resulting mixture was heated to 50 oC and allowed to stir for 11 h.  
The reaction was then permitted to cool to 23 oC at which time the pH was adjusted to 3 
via dropwise addition of 1M HCl.  5 mL 20% i-PrOH in CH2Cl2 was then added and the 
layers were separated.  The aqueous layer was extracted with an additional 2 x 5 mL 20% 
i-propanol in CH2Cl2.  Solid NaCl was then added to the aqueous layer until saturation was 
obtained, and it was further extracted with 2 x 5 mL 20% iPrOH in CH2Cl2.  The combined 
organic layers were dried over Na2SO4, filtered and concentrated to yield 17.3 mg of an 
oil.  HPLC purification afforded 4.9 mg (65%) of a colorless oil.  HRMS (m/z): [M-H]- 
calcd. for C30H32N2O7Na 444.2028, found 444.2031.  
1H NMR (400 MHz, Methanol-d4) 
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δ 8.03 – 7.99 (m, 1H), 7.96 (s, 1H), 7.46 – 7.41 (m, 1H), 7.23 – 7.14 (m, 2H), 6.84 (dt, J = 
15.4, 6.9 Hz, 1H), 5.83 (d, J= 15.6 Hz, 1H), 5.11 (td, J = 10.5, 4.7 Hz, 1H), 4.74 (s, 1H), 
4.04 (dd, J = 9.6, 6.2 Hz, 1H), 3.89 – 3.81 (m, 1H), 3.79 (q, J = 2.9 Hz, 1H), 2.29 – 2.17 
(m, 3H), 2.00 (ddd, J = 13.4, 11.2, 3.1 Hz, 1H), 1.70 – 1.58 (m, 1H), 1.58 – 1.42 (m, 5H), 
1.23 (d, J = 6.3 Hz, 3H), 1.16 (d, J = 6.0 Hz, 3H). 
Representative procedure for epoxide opening: 
To a suspension of 82.4 mg (3.39 mmol) of magnesium turnings in 0.44 mL dry THF was 
added 0.52 mL (3.4 mmol) bromoalkene in 2.9 mL dry THF dropwise over the course of 4 
minutes.  The resulting suspension was brought to reflux and stirred for 12 h until all 
magnesium had been consumed.  The resulting cloudy, pale-yellow mixture was allowed 
to cool to 25°C.  To a separate flask was added 34.2 mg (0.238 mmol) CuBr in 5 mL dry 
THF.  This suspension was cooled to -78°C.  To this chilled suspension was added the 
previously synthesized Grignard reagent dropwise over 3 minutes via syringe.  This 
resulting suspension was allowed to stir for 10 minutes, upon which it turned dark gray 
with black solids.  To this suspension was added 0.17 mL (2.4 mmol) (R)-(+)-propylene 
oxide at once, upon which it turned from dark gray to black.  The suspension was allowed 
to warm to 25°C and was stirred for 3 h.  To the black suspension was added 4 mL sat. 
NH4Cl at once.  The aqueous layer was separated from the organic layer and then extracted 
with 3 x 10 mL THF.  The resulting organic extracts were dried over MgSO4 and filtered 
to obtain 509.3 mg of yellow oil after rotary evaporation. 
Synthesis of (R)-hept-6-en-2-ol (epoxide opening):   
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Began with 156.8 mg (R)-(+)-propylene oxide, (no purification necessary) yielded 175.4 
mg (57%) of a light yellow liquid.   [α]D25 = 38.3, c 0.73 (CH2Cl2);  1H NMR (250 MHz, 
CDCl3) δ 5.81 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H), 5.09 – 4.88 (m, 2H), 3.79 (h, J = 6.0 Hz, 
1H), 2.16 – 1.95 (m, 2H), 1.95 (s, 1H), 1.60 – 1.31 (m, 4H), 1.18 (d, J = 6.2 Hz, 3H);  13C 
NMR (63 MHz, CDCl3) δ 138.63, 114.50, 67.87, 38.65, 33.62, 24.97, 23.42. 
Synthesis of (R)-oct-7-en-2-ol (epoxide opening):   
 
Began with 596.1 mg (R)-(+)-propylene oxide, (no purification necessary) yielded 322.5 
mg (88%) of a light yellow liquid.   [α]D25 = 7.1, c 0.59 (CH2Cl2);  1H NMR (250 MHz, 
CDCl3) δ 5.77 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H), 5.04 – 4.84 (m, 2H), 3.75 (q, J = 5.9 Hz, 
1H), 2.01 (h, J = 5.7 Hz, 3H), 1.47 – 1.22 (m, 5H), 1.14 (d, J = 6.2 Hz, 3H);  13C NMR (63 
MHz, CDCl3) δ 138.70, 114.18, 67.79, 38.98, 33.57, 28.74, 25.09, 23.26. 
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CHAPTER 2: CHEMICAL GENETIC STUDIES ON CHEMOSENSATION IN 
THE MODEL ORGANISM CAENORHABDITIS ELEGANS, PART II: IMPACT 
OF ASCAROSIDES ON DAUER FORMATION AND SPERM MOTILITY 
2.1 Introduction 
 As previously mentioned in Chapter 1, C. elegans has been used as a model 
organism since the 1960s.  Brenner developed and popularized its use as a model organism 
for biological research, and in 2002 he was awarded the Nobel Prize in Physiology and 
Medicine for his efforts.1  C. elegans has now been used by molecular biologists to study 
development, aging, stress resistance, metabolism, neurobiology, cancer, pathways of 
signal transduction, anthelmintics, and genetics.2  Now, the wealth of knowledge gained 
from the past 50 years of research is allowing a new field to emerge.  Chemists have 
become interested in chemical genetics and chemical biology studies in C. elegans to 
explore how small molecules affect larger biological processes.  This relatively new area 
of research helped to inspire the work presented herein.  
 Specifically, our interests concern how small molecule pheromones affect 
important signaling pathways in C. elegans.  Both dauer formation and reduced sperm 
motility are shown to be inducible by treatment with ascaroside pheromones. Target 
ascaroside natural products and analogs were successfully synthesized in 4-5 steps each 
from dibenzoyl ascarylose and screened for activity in dauer formation assays and for 
activity regarding sperm function.  Results from both studies, now published, are discussed 
in this chapter. 
2.2 The C. elegans Dauer Stage 
 Though C. elegans has been used for biological research since the early 1960s, its 
use in chemical biology has emerged only recently.  For example, it has been determined 
that small molecule pheromones control development3 and behavior4 in C. elegans via 
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regulation of important signaling pathways (TGF-β and IGF-1).5  One of the most 
interesting and well-studied phenomena controlled by these pathways is an alternate larval 
stage during C. elegans early development.  Referred to as the process of dauer diapause, 
the “dauerlarva” was first described by Cassada & Russel in 1975.6  The word dauer is of 
German origin and means steady, continuous or permanent.  Though the dauer larvae were 
studied to some extent, the exact reasons for diapause remained elusive for nearly a decade.  
Then, in 1984, Golden & Riddle determined that adverse environmental conditions such as 
food scarcity, high temperature, and overcrowding (high concentration of excreted 
pheromones) are triggers for dauer formation.7  Figure 2.1 depicts the nematode life cycle.   
Figure 2.1 Caenorhabditis elegans developmental stages.  
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 A normal development cycle begins with an egg, which hatches to become an L1 
larva.  The L1 then advances to become L2, L3, and L4 before finally reaching adulthood.  
However, when met with adverse conditions, an early stage larva (L1 or L2) may instead 
enter the dauer stage.  While in the dauer stage, the larva rarely move, do not feed, and 
have thickened cuticles that protect against harsh environmental conditions.  By surviving 
off of fat stores, the non-ageing dauer larva may persist for several months, much longer 
than the normal C. elegans lifespan of 2-3 weeks, until it is again met with favorable 
conditions.8  At that time, the dauer larva can enter the L4 stage of development and 
progress into a normal adult. 
 C. elegans secretes ascaroside pheromones and senses their concentration via 
chemosensation with sensory neurons located in its head.  In this way, the nematodes are 
able to gain important population information from their surroundings.7  At high population 
density (high ascaroside concentration), dauer formation takes place as a preventative 
measure to ensure survival.  The dauer larvae will then remain in that state of suspended 
animation until the concentration of pheromones in the environment is reduced.  A 
competing, dauer-inducing signal, still of unknown origin, is referred to as the “food 
signal.”  The food signal gives C. elegans indications of the abundance of food in its 
environment and can prevent dauer formation even in cases when population density and 
ascaroside concentration are high.  Both the ascaroside pheromone signal as well as the 
food signal are important for dauer formation and for the return to normal development.3 
Sensory neurons located on the head of C. elegans express hundreds of G protein-
coupled receptors (GPRCs) which sense ascaroside pheromones.9  Ascaroside binding to  
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GPCRs has been documented in a few different ways.  When gpa-2 and gpa-3 (two alpha 
subunits of GPCRs) were upregulated, dauer formation occurred; when those subunits were 
mutated, dauer formation was not induced.10  Of the neurons associated with GPCR 
expression in C. elegans, the ASI and ASJ neurons are particularly significant because of 
their role in the regulation of IGF-1 and TGF- signaling pathways.5d, 11  When ascaroside 
pheromones are detected, the IGF-1 and TGF- signaling pathways are downregulated due 
to neuron downregulation of secondary messengers such as TGF- and  insulin-like 
peptides.11  As mentioned in Chapter 1, pathways like TGF-β and IGF-1 are known to 
influence growth, metabolism, development, longevity, and stress-resistance in higher 
organisms including humans.12  IGF-1 has been shown to be important in the aging process 
of C. elegans.  When the C. elegans IGF-1 receptor (DAF-2) was mutated, the lifespan of 
the worm doubled.13  Increased lifespan was also observed when the IGF-1 pathway was 
manipulated in mice as well as the fruit fly Drosphila melanogaster.14  The IGF-1 pathway 
also seems to affect cancer risk and growth of cancer cells.  In fact, it has been demonstrated 
that when IGF levels are decreased, growth of cancer cells also decreases.15  Also, there is 
evidence that diets which downregulate IGF-1 result in a lower risk of developing cancer 
at all.16 
The TGF-β pathway is also conserved in higher organisms such as humans, and is 
associated with diseases such as cancer17 and Alzheimer’s disease.18  Remarkably, for 
breast and skin cancers, TGF-β is upregulated in some cases and shown to aid in tumor 
progression.  However, for gastric and pancreatic cancer, TGF-β is essentially turned off.17  
These conflicting results for different types of cancer speak to the complexity of the 
relationship between cancer and TGF-β.  Furthermore, Alzheimer’s patients have shown 
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higher concentrations of TGF-β in blood and cerebral fluid, suggesting a TGF-β  
relationship with the disease.18  The study of IGF-1 and TGF-β pathways may indeed 
provide useful insight and perhaps aid in the fight against such diseases. 
To assess downregulation of IGF-1 and TGF-β in C. elegans, we decided to screen 
the dauer-inducing ability of ascarosides.  As shown in Chapter 1, we decided to synthesize 
a battery of natural and synthetic ascaroside analogs for screening in dauer formation 
assays.  We hypothesized that these studies could help to develop an SAR between 
ascarosides and their GPCRs, as well as provide useful insight about the way C. elegans 
uses the IGF-1 and TGF-β signaling pathways.  Results could be extrapolated to higher 
organisms and utilized in important research of diseases, aging, stress-resistance, 
development, and metabolism. 
2.3 Results and Discussion of Dauer Studies 
 Upon synthesis of ascaroside pheromones and analogs, the dauer-inducing ability 
of each ascaroside was determined both at 220 nM, which is near the EC50 for already-
identified compounds, and 6000 nM, a very high concentration that would show if any 
activity existed at all.19  The ascarosides were mixed with nematode growth media (NGM) 
agar and previously heat-killed E. coli (food source) before being poured into plates.  Live 
C. elegans nematodes were then exposed to the created environment and allowed to lay 
eggs.  After 68-72 hours of incubation at 25oC, plates were analyzed, with dauer larva being 
easily recognizable under microscope by their smaller size and lack of movement.  In this 
way, dauer formation percentage was determined. 
 The activities of all synthesized compounds were screened in this manner, and the 
results are shown in Figure 2.2 (arrows at bottom of figure indicate compounds synthesized 
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by this researcher).  Some naturally occurring ascarosides had activity up to 90% dauer 
formation at 220 nM and near 100% at 6000 nM.  The highest activity for synthetic analogs 
at low concentration (220 nM) were IC-asc-C6-MK at 40% followed by asc-C10-OH at 
20% and asc-C10-MK at 15%.  At 6000 nM, several synthetic analogs showed activity 
with the maximum of asc-C10-MK remaining under 60%.  Interestingly, none of the asc-
C# or asc-ΔC# series had significant activity at 220 nM even when they only varied by 
one carbon or one degree of unsaturation.  At 6000 nM, the most significant activity was 
about 40% for asc-C9, the saturated analog of naturally occurring asc-ΔC9.  Synthetic 
analogs of these series showed the most activity when the chain length was 5, 7, or 9, all 
of which occur in one of the natural compounds.  Thus, for this series, side chain length 
was more important than degree of unsaturation at 6000 nM, though both were extremely 
important at 220 nM.   
 
 
 
 
 
 
 
Figure 2.2 Dauer formation activity of naturally occurring and synthetic ascarosides* 
*From reference 26, reprinted with permission from AAAS 
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Not surprisingly, IC-asc-ΔC9, shown to be a naturally occurring compound, had 
25% dauer forming activity at 220 nM and 40% at 6000 nM.  The only synthetic compound 
containing the IC head group also showed strong activity at 220 nM with about 40% dauer 
formation.  Remarkably, at high concentration inhibited dauer formation, with less than 
10% dauer formation at 6000 nM.  This phenomenon was only observed with one other 
compound, the naturally occurring IC-asc-C5, possibly due to the IC moiety.  Other than 
IC-asc-C6-MK, synthetic analogs showed very little activity at 220 nM across the board.  
Less than half showed significant activity at 6000 nM.  These findings suggest that dauer 
formation activity of ascarosides is highly dependent on structure.  Variance of a single 
carbon, one degree of unsaturation, or the terminal group in a side chain is enough to 
drastically alter activity.  These results lead us to conclude that the GCPRs that bind 
ascarosides are highly selective despite the abundance and structural variation known to 
exist among these compounds.20  This selectivity is not surprising considering the fact that 
C. elegans nematodes share their environment with other nematodes like C. briggsae, 
which produces similar compounds.21  We hypothesize that, if receptor binding was 
promiscuous, misinformation by cross-talk between nematode species could be detrimental 
for survival. 
2.4 Sperm Motility in C. elegans 
 Environmental factors are known to affect fertility in many animals, but the direct 
causes are not always well understood.22  One important class of molecules that is known 
to influence reproduction in humans and other mammals is the set of fatty-acid derived 
signaling molecules called prostaglandins.23  The specific role of prostaglandins in 
reproduction is not entirely understood, and monitoring gamete function in the 
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reproductive tract is considerably difficult.  C. elegans is known to produce F-class 
prostaglandins, which have been shown to guide sperm to their fertilization site 
(spermatheca).24  The transparent epidermis of C. elegans’ allows for direct observation of 
fluorescently labeled sperm and it was shown that, when there is a mutation in the daf-7 
TGF-β ligand, sperm-targeting defects arise.25   
2.5 Results and Discussion of Sperm Motility Studies   
Figure 2.3 shows the anatomy and important fertilization regions of an adult 
nematode.  Indicated are the sensory neurons (ASI), nerve ring (NR), oocytes (O), 
spermatheca (S, outlined in yellow), vulva (V), and fertilized eggs (E).  Sperm, which are 
injected through the vulva, must find their way around the fertilized eggs and into the 
spermatheca.  The nematode uterus is divided into three zones, Z1, Z2, and Z3 to further 
specify location and quantification of sperm. 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 Anatomy of adult C. elegans hermaphrodite* 
*From reference 26, reprinted with permission from AAAS 
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With this information in hand, we hypothesized that TGF-β promotes prostaglandin 
synthesis in C. elegans.  In order to test this hypothesis, the previously mentioned 
ascarosides asc-C6-MK and IC-asc-ΔC9 were used to study downregulation of TGF-β 
and observe any effect on sperm function.26  Figure 2.4 shows the results of treatment with 
ascarosides.  In the control experiment using wild type C. elegans, one hour after mating 
over 90% of sperm had found their way to Z3, the region of the uterus containing the 
spermatheca.  When wild type C. elegans were treated with synthetic asc-C6-MK and IC-
asc-ΔC9 ascarosides, less than 60% of sperm were able to arrive in the Z3 region one hour 
after mating.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4 Ascaroside effects on sperm function* 
*From reference 26, reprinted with permission from AAAS 
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This indicated a direct correlation between downregulation of the TGF-β pathway 
and decrease in sperm motility (likely via suppression of daf-7).  Indeed, it was also shown 
that when daf-7 mutants (mutants where daf-7 was forced to express via the ASI-specific 
gpa-4 promoter)27 were given the same treatment, sperm function was unmolested, 
indicating that suppression of daf-7 by C6-MK and IC-asc-ΔC9 was almost certainly the 
cause of TGF-β downregulation. 
2.6 Conclusions 
 In conclusion, 12 synthesized ascarosides were screened for activity in dauer 
formation assays.  Analogs varied in chain length, degree of unsaturation, terminal 
functionality and head group.  Generally speaking, synthetic analogs did not show high 
dauer-inducing ability unless they bore a high degree of similarity to naturally occurring 
ascarosides.  This suggests that the GPCRs which bind these ascarosides are highly 
selective, possibly an evolutionary result that prevents cross-talk between nematode 
species.  Side chain length was the most important factor for analogs not containing an IC 
moiety.  When a synthetic side chain length was used, almost all activity ceased.  However, 
some natural side chain lengths still had activity when the degree of unsaturation was 
altered.  So far, all IC-containing compounds have been shown to induce dauer formation, 
though only one synthetic analog has been screened. 
 Sperm motility was reduced via treatment with two synthetic versions of naturally 
occurring ascarosides.  Interestingly, a more detailed theoretical map of the TGF-β 
signaling pathway was elucidated, beginning with treatment by ascarosides and ultimately 
climaxing in reduced sperm motility.  First, asc-C6-MK and IC-asc-ΔC9 ascarosides were 
shown to repress expression of daf-7, an important TGF-β ligand normally present in ASI 
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sensory neurons.  Suppression of daf-7 is known to downregulate the TGF-β pathway, 
which is known to result in a decrease in production of prostaglandins.  Specifically, F-
class prostaglandins are known to play a critical role in guiding sperm to the fertilization 
site.  Therefore, treatment with the two above mentioned ascarosides directly resulted in a 
decrease of prostaglandins, which led directly to decreased sperm function.  
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CHAPTER 3: EFFORTS TOWARD SYNTHESIS OF THE HASUBANAN 
ALKALOID DELAVAYINE: A PHOTO-SN1 APPROACH 
 
3.1 Introduction 
 The hasubanan alkaloids are a family of over 40 structurally related compounds 
isolated from several species of vines belonging to the genus Stephania.1  These 
structurally exciting synthetic targets are similar to the morphines, and some members of 
this class of alkaloids have demonstrated activity for human δ-opiod receptors.2  We 
conceived a novel photochemical approach to gain efficient entry into the hasubanan 
tetracyclic ring system.  Specifically, we imagined a cascade cyclization utilizing the 
photo-SN1 reaction.
3  The photo-SN1 reaction’s ultraviolet light-promoted generation of a 
triplet phenyl cation leads to a unique manifold not usually accessible under thermal 
conditions.3  To quickly provide proof of concept, a substrate for the proposed 
photocyclization was completed in 5 linear steps from 3,4,5-trimethoxybenzyl cyanide.  If 
the proposed step were to give the desired result, the intermediate obtained would be only 
a few steps from hasubanan alkaloid delavayine and would open the door for many other 
substrates to be attempted.   
3.2 Hasubanan Alkaloids 
The alkaloid hasubanonine was first isolated from the Japanese vine Stephania 
japonica in 1951.4  Its structure was erroneously assigned twice before Matsui et. al 
determined it correctly in 1964 using a combination of NMR techniques and degradation 
studies.5  As a result of the striking similarity between the structure of morphine 3.1 
(Scheme 3.1) and that of hasubanonine 3.2, this alkaloid attracted considerable attention.  
Since that initial discovery, over 40 compounds sharing the same tetracyclic backbone have 
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been isolated from several species of the genus Stephania.1  This structurally interesting 
family of compounds have become known as the hasubanan alkaloids.   
 
 
 
 
Scheme 3.1 Structures of morphine and hasubanonine 
For some time, no biological acitivy was reported for these compounds, but in the 
late 1990s it was noticed by Shultz and coworkers that the orientation of the heterocyclic 
ring in relation to the aromatic ring in the hasubanan alkaloids was precisely inverse to that 
of the morphines.6  For this reason, it was hypothesized that the unnatural enantiomers of 
the hasubanan alkaloids may be better suited to confer activity by having morphine-like 
analgesic effects.  Shultz’s 1998 synthesis of (+)-cepharamine, the mirror image of the 
natural product isolated from Stephania cepharantha, set the stage for testing this 
hypothesis.6  Though several other hasubanan alkaloids were also synthesized in racemic 
or asymmetric fashion, no biological activity for these was reported.  Then, in 2010, it was 
shown that several of the naturally occurring alkaloids, including two newly isolated, have 
binding activity for the δ-opiod receptor in humans.2  This new information is rather 
thrilling given that binding to the δ-opiod receptor is known to produce analgesia and to 
cause antidepressant effects.7  Besides being fascinating synthetic targets, the hasubanan 
alkaloids remain as promising leads for drug development. 
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3.3 Photo-SN1 Reaction 
Italian chemists Fagnoni and Albini have pioneered transformations via 
photochemical cleavage of aryl-diazonium salts, aryl chlorides, fluorides, mesylates, 
triflates, and phosphates leading to triplet phenyl cations.3, 8  For electron-donating group 
(EDG)-substituted aryl chlorides and fluorides in polar media, flash photolysis studies have 
determined that cleavage occurs from the triplet state.8  The difference between a singlet 
and triplet phenyl cation is important and leads to significant variances in chemical 
selectivity.  A singlet phenyl cation is localized with a vacant σ-orbital and 6 π electrons 
(Scheme 3.2) and will often react with a lone pair-bearing nucleophile.3  The triplet phenyl 
cation, however, is delocalized with 5 π electrons and a single electron in the σ-orbital.  
This gives the triplet phenyl cation carbene character at the dicoordinate carbon.  Thus, the 
triplet phenyl cation is predisposed to react with a π-nucleophile, making it a better choice 
for C-C bond formation.3 
 
 
 
Scheme 3.2 Singlet vs. triplet phenyl cation 
An example of the proposed mechanism for triplet phenyl cation reaction with π 
nucleophiles, known as photo-SN1, is shown in Scheme 3.3.  Vertical arrows over lines 
represent the spin of electrons in their orbitals, with higher energy orbitals shown above 
those of lower energy.  First, a ground state singlet (S0) molecule, a molecule in which all 
occupied orbitals contain two antiparallel spin (spin-paired) electrons, absorbs a photon of 
UV radiation.  This absorbed energy causes an electron to be promoted to a higher energy 
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orbital, producing a singlet excited state (S1).  The singlet excited state is defined by having 
two orbitals that are occupied by one electron each, with the spin of the electrons still 
paired.  One electron then inverts its spin via intersystem crossing (ISC) and results in two 
orbitals that each contain one electron of parallel (unpaired) spin.  This electronic state is 
referred to as the triplet excited state (T1).   
Once the triplet excited state is achieved, heterolytic cleavage of the C-Cl bond 
results in a triplet phenyl cation.  As previously discussed (Scheme 3.2), one electron is 
delocalized in the ring along with the positive charge while the other is localized in an 
orthogonal sp2 orbital.  This species behaves similarly to a triplet carbene.  Addition of a π 
nucleophile results in a triplet diradical that must undergo intersystem crossing to the 
singlet excited state before the two radicals can unite to form a bond.  The result of this 
radical termination is a singlet ground state cyclopropane intermediate which may undergo 
subsequent nucleophilic attack to rearomatize the ring and further construct complexity.  
This recently discovered chemistry inspired our photochemical approach to the synthesis 
of hasubanan alkaloid delavayine. 
Scheme 3.3 Example of photo-SN1 mechanism 
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3.4 Results and Discussion 
 
Photo-SN1 chemistry has now been used to accomplish arene cross-couplings, 
allylations, and alkynylations along with reactions such as the type shown in Scheme 3.3, 
and others.9  In these ways, the photo-SN1 has shown potential as a substitute for cross-
couplings which are usually accomplished with metal catalysis.8  While studying the photo-
SN1 mechanism, we realized that intramolecular examples of cyclization did not exist in 
the literature.  Therefore, we proposed that intramolecular arene coupling could be 
followed by the addition of a nucleophile already present on the same structure.  A reaction 
of this type would add considerable molecular complexity at once.  Thus the hasubanan 
alkaloids were examined as synthetic targets, with delavayine (3.3, Scheme 3.4) being 
chosen as the first to attempt.   
 
 
 
 
 
 
 
 
 
Scheme 3.4 Original retrosynthetic analysis of delavayine 
The idea of arene coupling followed by nucleophilic attack from the nitrogen to 
access the tetracyclic core is shown in the retrosynthetic analysis in Scheme 3.4.  If 
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intermediate 3.4 was in fact formed from 3.5 in this reaction, the structure would be only 
two steps from 3.3.  Photosubstrate 3.5 was to be synthesized via Wittig reaction between 
aldehyde 3.6, attainable through reduction and formylation of 3,4,5-trimethoxybenzyl 
cyanide, and ylide 3.7, accessible by reacting 6-chloropiperonyl chloride with 
triphenylphosphine followed by treatment with a strong base.  It was unclear whether a 
protecting group would be necessary for the nitrogen during cyclization or even for the 
entire synthesis.  If not, such a total synthesis would be only 7 linear steps, the shortest of 
any hasubanan alkaloid to date. 
Synthesis of photosubstrate 3.5 began with the reduction of 3,4,5-trimethoxybenzyl 
cyanide.  Reduction was attempted several times with lithium aluminum hydride to no 
avail, so a new method of reduction was sought out.  Raney nickel reduction under 1 atm 
H2 gave a quantitative yield of the primary amine 3.8 with no purification necessary 
(Scheme 3.5).  Next, formylation of 3.8 was needed to produce proposed intermediate 3.6.  
Although several methods for this transformation were attempted, including Duff reaction, 
Vilsmeier-Haack reaction, orthoester formylation, and lithiation/DMF formylation, no 
desired product was ever observed even with protection of the primary amine. 
 
 
 
 
 
 
Scheme 3.5 Early synthetic work toward photosubtrate 
57 
 
We then devised an alternate route to photosubstrate 3.5.  Shown in Scheme 3.6, a 
methyl carbamate-protected version (3.5a) of photosubstrate 3.5 would now be constructed 
by Heck coupling of alkene 3.9, to be formed via Wittig reaction of 6-chloropiperonal, and 
aryl bromide 3.10, accessible by reduction, protection, and subsequent bromination of 
3,4,5-trimethoxybenzyl cyanide. 
 
 
 
 
 
 
 
 
Scheme 3.6 New retrosynthetic plan for photosubstrate 
Depicted in Scheme 3.7, 6-chloropiperonal was successfully converted into 
terminal alkene 3.9 via Wittig reaction with methylenetriphenylphosphorane.  Aryl 
bromide 3.10 was also successfully synthesized via NBS bromination of intermediate 3.8a 
(methyl carbamate-protected version of primary amine 3.8).  However, the Heck coupling 
of 3.8a and 3.9 was not successful under any attempted conditions.  At this point, we were 
concerned that the aryl bromide simply wasn’t reactive enough.  Thus, the aryl iodide 
analog 3.11 was synthesized via reaction of 3.8 with NIS.  After failed Heck coupling with 
Pd(PPh3)4 as catalyst, successful Heck coupling of 3.9 and 3.11 was achieved using 
palladium acetate to give stilbene intermediate 3.12 as a single isomer.  Reduction of 3.12 
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with 10% palladium on activated carbon and 1 atm H2 gave 3.5a, the protected version of 
target photosubstrate 3.5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.7 Synthesis of target photosubstrate 
After synthesis of the desired substrate was complete, we attempted the proposed 
photocyclizations.  Thus, substrate 3.5a was irradiated with an Hg arc lamp for 2 hours in 
an acetonitrile/water mixture.  After irradiation, TLC showed that a single product had 
formed, though some starting material was still present.  Isolation of the product showed 
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an unexpected result.  It appeared that one of the methyl groups was no longer attached to 
the molecule, and that cyclization of the nitrogen did not occur.  Indeed, upon 2D NMR 
studies along with mass spec, energy calculations, and NMR predictions the product was 
confirmed to be 3.13, (29%, Scheme 3.8).  These results led us to believe that our proposed 
pathway was indeed viable, but went astray at the last step.   
 
 
 
 
 
 
 
 
 
 
Scheme 3.8 Photochemical cyclization pathways 
After expected generation of triplet phenyl cation 3.14, cyclization occurred leading 
to diradical intermediate 3.15.  The two resulting radicals then formed a bond leading to 
predicted cyclopropane intermediate 3.16.  From intermediate 3.16, we had anticipated 
cyclization of the nitrogen and loss of a proton to form a 5-membered heterocycle and give 
intermediate 3.4a containing the hasubanan tertracyclic ring system.  Instead, internal 
fragmentation of the cyclopropane intermediate formed an oxonium which was hydrolyzed 
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resulting in formation of 3.13.  These pathways are indicated in Scheme 3.8 by the blue 
and red arrows.  
Strategies to promote cyclization and prevent loss of a methyl group included 
deprotection of the nitrogen to liberate the primary amine, and use of a polar but less 
nucleophilic solvent like trifluoroethanol.  Deprotection of the nitrogen was performed, yet 
the free amine substrate gave analogous results.  Also, when the less nucleophilic solvent 
trifluoroethanol was used, the reaction did not proceed.  Another problem with the reaction 
was poor yield.  Regardless of duration, yield for this reaction was never above 30%, and 
the remainder of the mass balance consisted of unconverted starting material.  We attribute 
this to the product of the reaction acting as a triplet quencher, therefore rendering the 
formation of the triplet phenyl cation inoperable above a certain concentration of product.  
In an attempt to overcome this problem, photosensitizers like acetone were added to the 
reaction mixture, but no increase in yield was observed. 
3.5 Experimental 
3.5.1 General Methods 
1H NMR and 13C NMR spectroscopy was conducted using a Bruker DPX-250, AV-
400 or AV-500 spectrometer.  Mass spectra were attained using an Agilent 6210 
electrospray time-of-flight mass spectrometer.  All materials were received from 
commercial suppliers and used without further purification.  Flash column chromatography 
was accomplished using high purity grade 60 Å silica gel (Fluka® Analytical).  Qualitative 
TLC was performed on aluminum sheets (Merck, silica gel, F254) and observed via UV 
absorption (254 nm) and staining with anisaldehyde or KMnO4.  Deuterated solvents were 
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acquired from Cambridge Isotope Labs.  All reactions were carried out under an 
atmosphere of dry nitrogen.   
3.5.2 Procedures and Characterization 
Synthesis of 3.8: 
 
 A vigorously stirred 20oC suspension of 500.0 mg (2.413 mmol) 3,4,5-
trimethoxylphenylacetonitrile, 1.5 mL 50% Raney nickel slurry in H2O, 15 mL NH4OH 
(28% NH3 basis), and 30 mL EtOH was vacuum-purged and backfilled with H2 gas and 
allowed to stir for 18h at 1 atm.  The suspension was then filtered and the volatiles 
evaporated in vacuo to afford 504.5 mg (quantitative yield) of a white solid that required 
no further purification.  1H NMR (400 MHz, CDCl3) δ 6.52 (s, 2H), 3.82 (s, 6H), 3.73 (s, 
3H), 2.87 (t, J = 7.2 Hz, 2H), 2.69 (t, J = 7.1 Hz, 2H);  13C NMR (101 MHz, CDCl3) δ 
154.65, 137.65, 137.31, 107.19, 61.22, 56.69, 44.26, 40.48; HRMS m/z calcd for 
C11H18NO3 [M+H]
+ 212.1281 found 212.1291. 
Synthesis of 3.8a:  
  
 To a stirred 0oC solution of 268.1 mg (1.270 mmol) 3.8 in 10 mL 10% Na2CO3 and 
5 mL THF was added 132 mg (1.40 mmol) methyl chloroformate in 5 mL THF.  The 
resulting mixture was allowed to stir for 30 min before addition of 20 mL H2O and 
subsequent extraction with 4 x 25 mL EtOAc.  The combined organic layers were dried 
with anhydrous Na2SO4, filtered, and the solvent was removed in vacuo to yield 337.9 mg 
(quantitative yield) of a white solid that required no further purification.  1H NMR (500 
MHz, CDCl3) δ 6.39 (s, 2H), 4.75 (s, 1H), 3.83 (s, 6H), 3.81 (s, 3H), 3.65 (s, 3H), 3.42 (q, 
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J = 6.8 Hz, 2H), 2.74 (t, J = 7.1 Hz, 2H); 13C NMR (126 MHz, CDCl3) δ 157.15, 153.47, 
136.77, 134.61, 105.79, 60.99, 56.26, 52.22, 42.37, 36.70; HRMS m/z calcd for C13H20NO5 
[M+H]+ 270.1336 found 270.1341. 
Synthesis of 3.9:  
 
 To a stirred -78oC solution of 788.4 mg (1.950 mmol) methyltriphenylphosphonium 
iodide in 20 mL dry THF was added 1.13 mL (2.28 mmol) n-butyllithium (2.02 M in 
hexane), resulting in a yellow mixture.  After 1 h, 300.0 mg (1.625 mmol) 6-
chloropiperonal dissolved in 5 mL THF was added dropwise over 2 minutes.  The solution 
was allowed to stir for an additional 1 h at which time it was allowed to warm to 20oC 
(solution turned orange) and stir for 5 h.  15 mL of saturated NH4Cl was then added at once 
and the resulting mixture was extracted with 3 x 20 mL CH2Cl2.  The combined organic 
layers were dried with anhydrous Na2SO4, filtered, and the solvent was removed in vacuo 
to yield 950 mg of a crude yellow oil.  Column chromatography (50 g silica gel, isocratic 
30% CH2Cl2 in hexanes) afforded 199.5 mg (67%) of a clear liquid.  Spectral data matched 
that previously reported in the literature.10 
Synthesis of 3.11:  
 
 
 To a stirred solution of 828.7 mg (3.077 mmol) 3.8a n 50 mL CH3CN was added 
900.0 mg (4.000 mmol) N-iodosuccinimide.  The solution was then heated to reflux in the 
absence of light and allowed to stir for 15 h before being allowed to cool to 20oC, at which 
time the volatiles were removed.  The mixture was then dissolved in 50 mL CH2Cl2 and 50 
mL 1 M Na2S2O3 and mixed vigorously.  The layers were then separated, and the aqueous 
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layer was extracted with an additional 2 x 50 mL CH2Cl2.  The combined organic layers 
were dried with anhydrous Na2SO4, filtered, and the solvent was removed in vacuo to yield 
1.32 g of a light yellow/orange oil. Column chromatography (120 g silica gel, gradient run 
from pure CH2Cl2 to 10% EtOAc in CH2Cl2) afforded 1.18 g (97%) of colorless oil.  
1H 
NMR (400 MHz, CDCl3) δ 6.62 (s, 1H), 4.87 (t, J = 6.4 Hz, 1H), 3.88 – 3.78 (m, 9H), 3.65 
(s, 3H), 3.38 (q, J = 7.0 Hz, 2H), 2.94 (t, J = 7.4 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 
157.18, 153.74, 153.29, 140.85, 137.21, 109.46, 88.28, 61.07, 60.85, 56.29, 52.21, 41.10, 
41.05.  HRMS m/z calcd for C13H19INO5 [M+H]
+ 396.0302 found 396.0306. 
Synthesis of 3.12: 
 
 
A stirred 20oC solution of 242.3 mg (0.6130 mmol) 3.11, 167.9 mg (0.9195 mmol) 3.9, 4.1 
mg (0.018 mmol) palladium(II) acetate, 9.7 mg (0.037 mmol) triphenylphosphine and 172 
μL (1.23 mmol) triethylamine in 30 mL DMF was sparged with nitrogen for 10 min then 
heated to 140oC.  After 1 h, an additional 4.1 mg palladium(II) acetate was added.  The 
solution turned dark and was allowed to stir for an additional 13 h.  It was then cooled to 
20oC and 60 mL H2O was added followed by 90 mL CH2Cl2.  The layers were separated 
and the aqueous layer was extracted with 2 x 90 mL CH2Cl2.  The combined organic layers 
were dried with anhydrous Na2SO4, filtered, and the solvent was removed in vacuo to yield 
380 mg of a red oil.  Column chromatography (35 g silica gel, gradient run from 100% 
CH2Cl2 to 10% EtOAc in CH2Cl2) afforded 210 mg (76%) of a colorless oil.  
1H NMR (500 
MHz, CDCl3) δ 7.45 (d, J = 16.3 Hz, 1H), 7.23 (s, 1H), 6.91 (d, J = 16.4 Hz, 1H), 6.86 (s, 
1H), 6.54 (s, 1H), 5.99 (s, 2H), 4.75 (s, 1H), 3.89 (s, 3H), 3.87 (m, 6H), 3.65 (s, 3H), 3.41 
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(q, J = 7.0 Hz, 2H), 2.94 (t, J = 7.4 Hz, 2H); 13C NMR (126 MHz, CDCl3) δ 157.21, 152.82, 
152.72, 147.77, 147.39, 141.53, 133.16, 130.11, 129.19, 125.91, 123.55, 123.24, 110.04, 
109.56, 105.65, 101.99, 61.15, 60.80, 56.23, 52.27, 42.17, 34.53;  HRMS m/z calcd for 
C22H25ClNO7 [M+H]
+ 450.1314 found 450.1302. 
Synthesis of 3.5a:  
 
 
 To a flask containing 34.5 mg (0.0767 mmol) 3.12 and 13.2 mg 10% palladium on 
activated carbon was added 10 mL EtOAc.  Stirring was then begun and the flask was 
vacuum-purged and back-filled with H2 gas, and allowed to stir for 17 h at 1 atm.  The 
suspension was then filtered through Celite® and volatiles were evaporated in vacuo to 
yield 59.3 mg of a crude oil.  Column chromatography (15 g silica gel, gradient run from 
100% CH2Cl2 to 5% EtOAc in CH2Cl2) afforded 26.4 mg (71%) of a colorless oil.  
1H 
NMR (500 MHz, CDCl3) δ 6.84 (s, 1H), 6.71 (s, 1H), 6.48 (s, 1H), 5.95 (s, 2H), 4.70 (s, 
1H), 3.92 (s, 3H), 3.86 (s, 3H), 3.84 (s, 3H), 3.68 (s, 3H), 3.43 – 3.31 (m, 2H), 2.78 (m, 
6H); 13C NMR (126 MHz, CDCl3) δ 157.18, 152.58, 151.92, 146.86, 146.72, 141.03, 
132.98, 132.43, 125.98, 125.30, 110.24, 109.96, 108.79, 101.76, 61.20, 60.89, 56.21, 
52.31, 42.29, 35.16, 33.38, 27.35; HRMS m/z calcd for C22H27ClNO7 [M+H]
+ 452.1471 
found 452.1460. 
Synthesis of 3.13:  
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 A solution of 3.1 mg (0.01 mmol) 3.5a in 4.5 mL previously irradiated and distilled 
CH3CN and 2.0 mL micron-filtered H2O was sparged with nitrogen for 20 min.  The 
solution was then irradiated with an Hg arc lamp for 2 h at which time the volatiles were 
removed in vacuo to yield 3.9 mg of a light yellow oil.  HPLC purification (Waters 1525 
Binary HPLC Pump, 2489 UV/Vis Detector, XBridge Prep C18 5µm 10x100 mm Reverse 
Phase Column, 20 min gradient from 95% H2O/MeCN to 5% H2O/MeCN) afforded 0.8 
mg (29%) of a pale yellow oil.  1H NMR (400 MHz, CDCl3) δ 6.71 (s, 1H), 6.23 (s, 1H), 
6.08 (s, 1H), 5.94 (s, 2H), 4.65 (s, 1H), 3.89 (s, 3H), 3.74 (s, 3H), 3.61 (s, 3H), 3.33 – 2.95 
(m, 4H), 2.54 (m, 1H), 2.30 (m, 2H), 2.01 (m, 1H); 13C NMR (101 MHz, CDCl3) δ 184.31, 
166.03, 158.32, 156.86, 148.50, 147.45, 138.68, 136.92, 134.90, 124.81, 105.34, 103.10, 
101.59, 61.32, 61.25, 60.73, 52.23, 39.43, 34.85, 32.71, 31.38; HRMS m/z calcd for 
C21H23NNaO7 [M+Na]
+ 424.1391 found 424.1368. 
3.5.3 DFT Calculations 
To gather more evidence for the structural assignment of 3.13, DFT calculations were 
performed on two possible isomers, referred to here as 6-membered and spiro.  Gaussian 
2009 (version C.01, 64 bit, Windows multiprocessor) was used with GaussView 5 to 
perform molecular orbital calculations on the two isomeric structures.   The DFT method 
was used with the B3YLP hybrid functional and 6-311G(d,p) basis set functions on all 
atoms.  Cambridge Crystallographic searches using the 2015 database found related 
structures for each proposed isomer that were used as one of the starting points for the 
Gaussian geometry optimization.  For the 6-membered ring isomer the related CCDC 
structure refcode OMEDEP was imported and modified using GaussView to produce the 
starting point for the optimization.11  CCDC structure refcode QOHJOO was imported, 
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modified, and used as the starting point for the geometry optimization on the spiro 
isomers.12  The methyl carbamate group was replaced with a simple NH2 group for both 
isomers.  Both isomers were also manually drawn in GaussView to generate somewhat 
different starting structures and conformations on which optimizations were also run.  
Figure 3.1 shows three dimensional structures of the two isomers. 
 
 
 
 
 
 
 
Figure 3.1 Possible isomers of 3.13 
The optimizations and frequency calculations on the two starting spiro isomer 
structures ended up with the same final structures that had the same overall energy.  
Optimization on the 6-membered ring isomer derived from the OMEDEP X-ray structure 
had the lower G energy by 1.6 kcals/mol relative to the “hand-drawn” 6-membered ring 
isomer.  All stretching frequencies calculated for the isomers were positive, indicating 
ground state structures.  The spiro isomer was calculated to have the lowest overall G 
energy, with the most stable 6-membered ring isomer higher by 2.9 kcals/mol.  This non-
trivial difference in relative energies is possibly due to extra ring strain induced by the 
quaternary center (Figure 3.1, 6-mem, carbon number 17) contained in the fused 6-
membered ring system.  The added rigidity of the 6-membered fused system compared to 
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the spiro may also cause increased steric interactions.  For example, the hydrogen atoms 
on carbons number 6 and 7 of the 6-membered isomer are forced toward each other. 
To gain additional evidence for the structural assignment of 3.13, NMR chemical 
shift calculations were carried out on the lowest energy isomers and the absolute 13C 
chemical shifts calculated were corrected using the internal Gaussian TMS 13C standard 
based on a DFT 6-311+G(2d,p) basis set.  Although the basis set used for the TMS 
reference differs somewhat from the 6-311G(d,p) basis set used for our calculation, we 
believed that it was close enough to allow a good relative comparison for the two isomers 
to the experimental 13C NMR data.  Figure 3.2 shows calculated 13C NMR chemical shifts 
compared to experimental, with the spiro isomer being a considerably better match.  This 
calculation provided additional evidence for the structural assignment, and together with 
the energy calculation allowed us to confidently assign the structure of compound 3.13 as 
the spiro isomer. 
Figure 3.2 NMR comparison 
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CHAPTER 4: REMOTE HYDROXYLATION BY RADICAL TRANSLOCATION 
AND POLAR CROSSOVER  
 
4.1 Introduction 
 Functionalization of aliphatic C-H bonds is a widely utilized and vitally important 
process in nature.1  Although the synthetic manipulation of unactivated C-H bonds was 
first discovered in the 1800s, use of these bonds in the synthesis of target molecules remains 
limited.  Indeed, for quite some time synthetic methods for C-H functionalization were 
harsh (highly reactive, prone to decomposition), low-yielding and unselective.2  Therefore 
the view persisted that this process could only be made selective and high-yielding by 
mimicking enzymes.3  In the past two decades, however, improvements to reaction 
conditions, selectivity, and yields have begun to render aliphatic C-H functionalization an 
advantageous step in synthetic planning.4 
 The benefits of incorporating C-H functionalization in total synthesis arise from 
shedding the usual constraints of retrosynthetic analysis.  Step-, atom-, and redox-economy 
can all be significantly improved by viewing the C-H bond as a useful functional group 
rather than an inert bystander.5  Employment of such strategies serves to improve overall 
synthetic efficiency.  By alleviating problems with scalability and the cost of production of 
complex drugs, the economic viability of such compounds can be realized to a greater 
extent.4 
 Two main strategies exist for the conversion of aliphatic C-H bonds.  The first 
strategy relies on the innate properties of the bond and its inherent reactivity while the 
second strategy uses external reagents to guide or direct the activation.6  A directing 
approach which has received considerable attention in recent years incorporates 
functionality which directs either the inner sphere of a transition metal or a metal-oxo 
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species to a remote C-H bond.7  Alternatively, a covalently attached directing group can be 
activated thermally, chemically, or photochemically to produce a radical which will 
translocate via hydrogen abstraction.8  A radical-promoted hydrogen atom transfer of this 
sort is often referred to as a radical translocation event.  Our recently developed approach 
to site-selective C-H functionalization falls into this category. 
4.2 Important Examples of Radical Translocation 
 
 
Scheme 4.1 Hofmann’s pioneering radical translocation 
 Though this reaction was discovered in the late 1800s and expanded upon in the 
early 1900s, the mechanism was not understood until much later.  In 1950, Wawzonek and 
Thelen researched and correctly predicted the mechanism which was studied further and 
confirmed by Corey and Hertler in 1960.9    
 
 
 
 
 
Scheme 4.2 Radical translocation mechanism 
As shown in Scheme 4.2, the mechanism begins with amine protonation followed 
by homolysis of the N-Br bond.  The resulting nitrogen radical cation abstracts hydrogen 
intramolecularly from an energetically favored carbon atom yielding an ammonium ion 
and a primary carbon-centered radical.  The primary radical begins a chain process by 
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abstracting bromine from another substrate molecule.  Finally, basic workup liberates the 
free amine which cyclizes via SN2 onto the bromine-bearing carbon, and loss of a final 
proton results in the observed product. 
 Breslow and coworkers famously employed guided radical translocation, which 
they referred to as remote oxidation, as a method for steroid functionalization in the early 
1970s.10   Cholestanols were esterified with various benzophenone acids which could be 
activated phototchemically for use as directing groups.  Among various results, ultraviolet 
irradiation of the benzophenone-4-acetic ester of 3α-cholestanol gave an impressive 55% 
yield of a single olefin between carbons 14 and 15 in ring D of the steroid backbone 
(Scheme 4.3).10  This groundbreaking site-selective remote functionalization led to 
increased interest in directed radical translocation. 
Scheme 4.3 Breslow’s photochemical remote olefination 
 Recently, a radical translocation method for desaturation has been developed by 
Baran and coworkers.11  This guided desaturation makes use of a novel benchtop-stable 
“portable desaturase” which can be attached to a substrate molecule where it facilitates C-
H bond functionalization.  The newly devised TzoCl (o-tosyl triazene chloride) group 
exhibits an aryl sulfonyl chloride for attachment to alcohol or amine moieties of a substrate 
before further reaction (Scheme 4.4).   
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Scheme 4.4 Attachment of Tzo directing group 
Ortho to the sulfonyl is a diethyl triazene which, upon treatment with two 
equivalents of strong acid, produces an aryl diazonium salt.  The redox-active aryl 
diazonium is reduced by TEMPO to release nitrogen and yield the aryl radical which 
performs an (unusual 1,7) intramolecular hydrogen abstraction at a nearby tertiary carbon.  
Oxidation of the resulting tertiary radical to carbocation by TEMPO+ and subsequent 
elimination give the desired olefin product.  When the reaction is complete, the Tzo 
directing group leaves behind a synthetically useful tosyl group.  Depicted in Scheme 4.5, 
this intriguing radical-polar crossover reaction helped to inspire our foray into remote C-H 
bond functionalization. 
Scheme 4.5 Baran’s remote desaturation process 
4.3 Results and Discussion 
 Our initial goal for C-H functionalization was to create a mild and versatile method 
for the selective installation of important functionalities at relatively unreactive positions.  
We recognized that there was ample room for expansion to the guided desaturation work 
completed by Baran and coworkers, and we thought to employ photoredox catalysis toward 
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that goal.  An approach involving a controlled hydrogen abstraction followed by oxidation 
to carbocation and subsequent rearrangement, elimination, or nucleophilic attack would 
open pathways to a plethora of desired bond formations.  One can imagine using such a 
reaction to replace C-H bonds with carbon bonds to oxygen (hydroxylation, etherification), 
nitrogen (Ritter amidation), carbon, fluorine and many others.   
 We envisioned a process to form an electron-poor aryl radical which could 
translocate via hydrogen abstraction to a nearby alkyl group.  Such translocations from 
relatively unstable aryl radicals to more stable alkyl radicals are known to be favorable and 
selective under the correct conditions.6-9, 11, 12  The low oxidation potential of the resulting 
alkyl radical allows mild reagents to effect SET oxidation to carbocation.13  To accomplish 
this goal, we proposed a pathway like that shown in Scheme 4.6. 
Scheme 4.6 Proposed pathway for remote functionalization 
 En route to our goal of mild conditions, we chose to employ visible light photoredox 
catalysis, a set of techniques which have gained recent traction by solving several 
challenging problems in organic synthesis.14  Beginning with an established directing 
group (See Tzo, Scheme 4.4), an arene diazonium 4.1 could be generated upon addition of 
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two equivalents of strong acid.  A diazonium of this type, with a reduction potential (Eo) 
in the range of -0.1 to +0.5 V vs. SCE could favorably undergo single electron reduction 
from an excited state photocatalyst such as fac-Ir(ppy)3
*, which has a Eo of -1.73 V vs. SCE 
in the excited state.14f, 15  After release of nitrogen, the resulting aryl radical 4.2 would then 
abstract hydrogen from an attached alkyl moiety.  This radical translocation event would 
generate alkyl radical 4.3 (Eox = 0-0.75 V vs. SCE) which could be oxidized to carbocation 
by the oxidatively quenched photocatalyst Ir(ppy)3
+ (Eo = +0.77 V vs. SCE), thus 
completing the catalytic cycle.13, 14f  Carbocation 4.4 would then intercept a nucleophile 
and yield the desired C-H functionalized product. 
 For our initial experiments, we synthesized isoamyl Tzo sulfonate ester 4.5 in one 
step from the corresponding alcohol.  We then degassed and irradiated (4 W blue LEDs, 
λ=455 nm) 4.5 and two equivalents of tetrafluoroboric acid in the presence of fac-Ir(ppy)3 
as photocatalyst, nitromethane as solvent, and methanol as nucleophile and cosolvent.   
Scheme 4.7 Initial experiments 
Shown in Scheme 4.7, an initial 7% yield of desired product 4.5d was obtained 
along with 18% of trivial reduction product 4.5b.  However, increasing the loading of 
photocatalyst had an immediate influence on yield.  10 mol% catalyst gave 31% yield of 
desired product and a similar amount of trivial reduction product.  Further increases of 
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photocatalyst as well as changes to the acid used (TFA, TfOH) did not have a noticeable 
effect on yield.  Any modifications to the solvent system or reduction of methanol 
equivalents led to no desired product formation.  
To test this system outside of a single substrate, we synthesized cyclopentyl Tzo 
ester 4.6 and menthyl Tzo ester 4.7 (Scheme 4.8).  While the cylopentyl substrate gave 25% 
of desired product 4.6d, the menthol derivative gave just 13% desired product 4.7d and 
32% of desaturation product 4.7c.  Both substrates produced noticeable amounts (not 
isolated) of trivial reduction products. 
Scheme 4.8 Additional preliminary results 
After these initial results, it was clear to us that this remote functionalization system 
was in need of improvement.  The most problematic issue was the consistent production of 
trivial reduction products (See Scheme 4.7, structure 4.5b).  These products are likely 
formed when a radical intermediate abstracts hydrogen from the electron-rich C-H bonds 
of methanol.   
 To remedy this problem we decided to look for a nucleophile which lacked 
electron-rich C-H bonds while also being neutral and relatively non-basic.  Though water 
has low miscibility with nitromethane, we attempted the same reaction conditions from 
Scheme 4.8, replacing methanol with water.  We were pleased to find that, on the first 
attempt of the new reaction conditions, isoamyl Tzo ester 4.5 yielded 57% of desired 
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hydroxylation product 4.5a with only trace evidence of trivial reduction product 4.5b or 
desaturation product 4.5c (Scheme 4.9).16   
Scheme 4.9 Initial remote hydroxylation experiment 
 At this point we decided to further optimize conditions for remote hydroxylation 
(Figure 4.1).  We found that a reaction time of less than 6 hours decreased yield (incomplete 
consumption of starting material) while anything more gave a consistent yield in the high 
50s (entries 1-4).  Decrease in photocatalyst loading resulted in significantly decreased 
yields (entries 5-6).  Exclusion of acid resulted in no observed conversion of starting 
material, (entry 7) while exclusion of photocatalyst gave 11% of desired product (entry 8).   
Interestingly, reactions run in the absence of light gave results of 40% after 4 hours 
and 50% after 18 hours (entries 9-10).  The ground state photocatalyst, fac-Ir(ppy)3 (E
o = 
+0.77 V vs. SCE), was not expected to undergo SET to reduce the generated aryl diazonium 
species (Eo range of -0.1 to +0.5 V vs. SCE), yet that seemed to be the case.  The 
unanticipated yields of this “dark reaction” prompted us to further investigate the reduction 
potential of the specific diazonium being generated during the reaction.  As shown in 
Scheme 4.10, diazonium 4.5e was generated from isoamyl Tzo ester 4.5 by addition of 2 
equivalents of strong acid.  Cyclic voltammetry of 4.5e was then performed (See section 
4.6.2 for experimental data) and Eo was found to be -0.12 V vs. SCE.  These findings tell 
us that, as expected, an electron transfer from ground state fac-Ir(ppy)3 to diazonium 4.5e 
would be energetically unfavorable (by 890 mV).  However, because this electron transfer  
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Figure 4.1 Optimization of reaction conditions  
Isolated yields.  *1 equiv. of TEMPO, 2 equiv. TFA at 60oC for 1.5 h without irradiation.  
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is coupled to a highly favorable and irreversible fragmentation (loss of nitrogen), the 
overall process is energetically favorable and precedents of similar events exist.17  
Scheme 4.10 Generation of diazonium and subsequent fragmentation 
Entry 11 showed that degassing of the reaction was unnecessary as 57% yield was 
observed under nitrogen with no freeze-pump-thaw procedure.  Entries 12 and 13 showed 
that higher concentration decreased yield while lower concentration had no observable 
effect.  The strong effect of solvent choice was apparent by the lack of any desired product 
isolated from entries 14-16.  Entry 17 showed the importance of water as a cosolvent when 
only trace amounts of desired product formed with 20 equivalents of water added.  Choice 
of photocatalyst was also imperative, with entries 18-21 resulting in a yield of 16% or less.  
Replacement of HBF4 with TFA resulted in a slight decrease in yield (entry 22).  Finally, 
and of great significance, we showed that this transformation could not be efficiently 
accomplished using the conditions of Baran and coworkers with the addition of water.11 
Even under optimized conditions for remote hydroxylation, yields of 4.5a did not 
exceed 60%.  Considering these results, the possibility of side products/pathways needed 
to be explored.  To this end, we irradiated 4.5 in CD3NO2 and D2O with 48% HBF4 and 10 
mol% fac-Ir(ppy)3 for 18 hours (Scheme 4.11).  The resulting crude mixture’s 1H NMR 
spectrum (in CD3NO2 after separating layers) showed desired product 4.5a as well as small 
amounts of desaturation product 4.5c and some unknown species.  Desaturation product 
4.5f and trivial reduction product 4.5b were not observed.  Hydrolysis product 4.8 (isoamyl 
alcohol) was observed although neither of its desaturated derivatives (4.8c, 4.8f) nor 
hydroxylated derivative 4.8a were detected.   
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Baran and coworkers also mentioned the possibility that an allylic tosylate like 4.5f 
may decompose.11  An expected product of such a pathway would be allylic alcohol 4.9, 
but none was detected during NMR studies.  In order to determine NMR yields of the 
observed products, use of various internal standards was attempted yet none gave useful 
data.  Instead, relative ratios of products were calculated and found to be 5.1 to 1.1 to 1 
respectively for 4.5a, 4.8, and 4.5c.  These findings, along with the notable presence of p-
toluenesulfonate salts in the D2O layer, suggested that a reaction intermediate was sensitive 
to hydrolysis while translocation products were stable under the reaction conditions.    
 
 
 
 
 
 
Scheme 4.11 NMR studies 
 In order to confirm the stability of hydroxylation product 4.5a and desaturation 
product 4.5c, each was resubmitted to standard reaction conditions (Scheme 4.9) and no 
degradation was observed in either case.  However, when Tzo ester 4.5 was subjected to 
standard conditions without photocatalyst (Scheme 4.12), considerable quantities of 
isoamyl alcohol 4.8 and diazonium 4.5e were observed.  Considering these results, the 
possibility of an electron-poor diazonium intermediate like 4.5e undergoing hydrolysis is 
much more likely than hydrolysis of a Tzo ester like 4.5 or translocation products like 4.5a 
and 4.5c (Scheme 4.11). 
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Scheme 4.12 Control experiment with absence of photocatalyst 
Next, we tested our photocatalytic remote hydroxylation method on several additional 
substrates to determine the scope.  Using our standard conditions (Scheme 4.9), we found 
that yields of this reaction ranged from 31-63% over a broad range of structures.  We also 
tested lower temperatures intended to suppress the competing desaturation reaction (Figure 
4.2).  Cyclopentyl substrate 4.6 yielded 41% of desired hydroxylation product 4.6a.  The 
same substrate gave a slightly increased yield of 48% when run at 6oC for 3 days, (slow 
consumption of triazene Tzo ester) but reaction of Tzo esters at temperatures lower than 
0oC were unreasonably slow.  This slowed consumption of starting material, in addition to 
the absence of diazonium or other intermediates in crude 1H NMRs, led us to believe that 
acid-promoted liberation of the diazonium ion from the triazene is the rate-determining 
step of the overall process.  Menthyl subtrate 4.7 afforded 31% hydroxylation product 
while citronellol derivative 4.10 gave 38%.  Leucine-derived substrate 4.11 gave 
exclusively lactone product 4.11a in 47% yield.  Higher yields resulted from benzylic Tzo 
esters 4.12, 4.13, and 4.15 (41-63%).  Tzo sulfonamides (substrates 4.14, 4.15, 4.16) also 
successfully underwent remote hydroxylation to give 34-56% yields.  Substrates 4.16, 4.17 
and 4.18 demonstrated that secondary benzylic systems were effectively converted to the 
corresponding alcohols (52-56% yields), while substrate 4.18 (56%) also revealed that 1,6-
abstractions are feasible with this method. 
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Figure 4.2 Substrate Scope 
Unless otherwise stated, reaction conditions were 0.2929 mmol substrate, 10 mol % fac-
Ir(ppy)3, 10 mL CH3NO2, 2 mL H2O and 2 equiv. of 48 % HBF4 were employed for 18 h 
irradiation.  *Experiment was conducted at 6oC for 3 days irradiation. 
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To confirm that the suggested pathway for this transformation was indeed feasible, 
an isotopic labeling experiment was conducted.  Shown in Scheme 4.13, 97% 18O-
containing water was used along with standard conditions.  The result of the experiment 
was hydroxylation with 90% 18O incorporation, which agreed with the original mechanistic 
hypothesis that water is trapping a carbocation. 
 
 
 
Scheme 4.13 18O labeling experiment 
After establishing photocatalytic remote hydroxylation we looked forward to 
demonstrating its useful application in organic synthesis.  We recognized that many 
important molecules contain the 1,3-aminoalcohol structural feature that our method can 
expediently construct.  Therefore, we converted hydroxylation product 4.17a (Figure 4.2) 
to the powerful antidepressant drug (±)-fluoxetine (Prozac®) in two steps.18  Shown in 
Scheme 4.14, the tosyl group resulting from conversion of Tzo triazene was used as a 
leaving group for nucleophilic addition of methylamine to give aminoalcohol 4.19.  This 
intermediate was then deprotonated with sodium hydride and converted to fluoxetine via 
nucleophilic aromatic substitution reaction with 4-chlorobenzotrifluoride.  Proceeding in 
only 4 steps from the inexpensive and simple 3-phenyl-1-propanol, this synthesis displays 
the rapid complexity introduced by our directed C-H functionalization method.   
 
 
Scheme 4.14 Unoptimized synthesis of fluoxetine 
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4.4 Future Work 
 Additional work toward C-H functionalization strategies will likely employ 
sulfones in place of previously used sulfonate esters and sulfonamides.  In this way, we 
aim to eliminate the problem of hydrolysis of our intermediates and increase yields.  
Sulfones may conceivably be prepared by modifying Baran’s procedure for production of 
TzoCl from the bromotriazene precursor.11  Alternatively, sulfones could be prepared from 
previously made TzoCl.19  Shown in Scheme 4.15, both methods for production of Tzo 
sulfones would go through sulfinate anion intermediates (structure 4.20).   Reaction of 
sulfinates with alkyl iodides would produce desired Tzo sulfone substrates with pendant 
alkyl chains such as 4.21.  We would then endeavor to direct a nucleophile to a desired 
location via our standard conditions (Scheme 4.9) to yield structures such as 4.22. 
Scheme 4.15 Proposed remote functionalization of sulfones 
4.5 Conclusions 
 Activation of relatively inert aliphatic C-H bonds plays a vital role in nature and is 
becoming increasingly useful in organic synthesis.  The abundance of this type of bond in 
organic structures makes it a desirable target for manipulation.  Currently, many existing 
synthetic methods for functionalization of C-H bonds are harsh and/or unselective.  As a 
step toward a solution to these problems, we have developed a photocatalytic directed 
hydroxylation (and methoxylation) of aliphatic C-H bonds which proceeds under mild 
conditions.  Our method has been tested on a variety of substrates and also applied to the 
total synthesis of the antidepressant drug fluoxetine (Prozac®).  This and similar systems 
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will be explored in the future to produce new and better ways for functionalizing aliphatic 
C-H bonds. 
4.6 Experimental 
4.6.1 General Methods 
1H NMR and 13C NMR spectroscopy was conducted using a Bruker AV-400 or 
AV-500 spectrometer.  Mass spectra were attained using an Agilent 6210 electrospray 
time-of-flight mass spectrometer.  Optical rotation was measured using a JASCO P-2000 
polarimeter.  All materials were received from commercial suppliers and used without 
further purification.  Flash column chromatography was accomplished using high purity 
grade 60 Å silica gel (Fluka® Analytical).  Qualitative TLC was performed on aluminum 
sheets (Merck, silica gel, F254) and observed via UV absorption (254 nm) and staining 
with anisaldehyde or KMnO4.  Deuterated solvents were acquired from Cambridge Isotope 
Labs.  TzoCl and CH3NO2 (reagent grade, 96%) were received from Sigma-Aldrich.  
Unless otherwise noted, all Tzo-containing compounds were synthesized according to 
literature procedure.1  All reactions were carried out under an atmosphere of dry nitrogen.  
Photocatalyzed remote hydroxylation reactions were conducted in round bottom flasks and 
irradiated with 4W blue LEDs (Creative Lighting Solutions, λmax=455 nm) which were 
wrapped around a beaker or crystallizing dish as pictured in Figure 4.3. 
4.6.2 Procedures and Characterization 
Representative procedure for remote hydroxylation - synthesis of 4.5a: 
 
 
 
To a vigorously stirred 20oC solution of 100.0 mg (0.2929 mmol) triazene 4.5 and 
19.2 mg (0.0293 mmol) fac-Ir(ppy)3 in 10 mL CH3NO2 and 2 mL deionized H2O was added 
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77 μL (0.59 mmol) 48% HBF4 via gas-tight syringe.  After 4 minutes, irradiation of the 
solution with blue LEDs (λmax=455 nm) commenced and the reaction mixture was stirred 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 Experimental Setup  
vigorously for 18.5 h.  10 mL of 5% NaHCO3(aq.) was then added at once followed by 10 
mL CH2Cl2 and the resulting layers were separated.  The aqueous layer was extracted with 
an additional 2 x 10 mL CH2Cl2.  The combined organic layers were dried over Na2SO4, 
filtered and concentrated to yield 117.3 mg of a brown residue.  Silica gel chromatography 
(gradient run from 20% EtOAc in hexanes to 30% EtOAc in hexanes) of the residue 
afforded 43.4 mg (57%) of a yellow oil.  1H NMR (400 MHz, CDCl3) δ 7.79 (d, J = 8.2 
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Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 4.20 (t, J = 6.8 Hz, 2H), 2.44 (s, 3H), 1.85 (t, J = 6.8 Hz, 
2H), 1.67 (br s, 1H), 1.21 (s, 6H);  13C NMR (101 MHz, CDCl3) δ 145.0, 133.1, 130.1, 
128.0, 69.8, 67.8, 41.8, 29.8, 21.8; HRMS (m/z) calcd for C12H18NaO4S [M+Na]
+ 
281.0818, found 281.0805. 
Representative procedure for NMR studies: 
To a vigorously stirred 20oC solution of 22.0 mg (0.0644 mmol) triazene 4.5 and 
4.2 mg (0.0064 mmol) fac-Ir(ppy)3 in 2.2 mL CD3NO2 and 0.44 mL D2O was added 17 μL 
(0.13 mmol) 48% HBF4 via gas-tight syringe.  After 4 minutes, irradiation of the solution 
with blue LEDs (λmax=455 nm) commenced and the reaction mixture was stirred vigorously 
for 18.5 h.  The aqueous and organic layers were then separated and placed directly into 
NMR tubes for analysis. 
Unless specifically noted, all Tzo-containing compounds were synthesized according to 
literature procedure.11  Synthesis and spectral data of known compounds 4.6 and 4.7 can 
also be found in reference 11. 
Synthesis of 4.5:  
 
Started with 2000.0 mg (6.902 mmol) TzoCl, 486.7 mg (5.521 mmol) isoamyl 
alcohol, 1349.0 mg (11.04 mmol) DMAP and 11.1 mL CH2Cl2.  Silica gel chromatography 
(gradient run from 10% EtOAc in hexanes to 20% EtOAc in hexanes) afforded 1724.3 mg 
(91%) of a yellow oil.  1H NMR (500 MHz, CDCl3): δ 7.81 (d, J = 8.1 Hz, 1H), 7.34 (s, 
1H), 6.96 (d, J = 8.1 Hz, 1H), 4.02 (t, J = 6.6 Hz, 2H), 3.80 (q, J = 7.2 Hz, 4H), 2.36 (s, 
3H), 1.66 (m, 1H), 1.48 (q, J = 6.7 Hz, 2H), 1.32 (t, J = 7.3 Hz, 3H), 1.24 (t, J = 7.3 Hz, 
3H), 0.80 (d, J = 7.0 Hz, 6H);  13C NMR (126 MHz, CDCl3): δ 149.3, 145.1, 130.5, 126.0, 
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125.0, 118.4, 68.7, 49.3, 42.2, 37.6, 24.4, 22.1, 21.7, 14.5, 11.3; HRMS (m/z) calcd for 
C16H27N3NaO3S [M+Na]
+ 364.1665, found 364.1658. 
Synthesis of 4.10: 
 
Started with 500.0 mg (1.725 mmol) TzoCl, 0.25 mL (1.4 mmol) citronellol, 337.0 
mg (2.758 mmol) DMAP and 2.8 mL CH2Cl2.  Silica gel chromatography (20% CH2Cl2 
and 5% Et2O in hexanes) afforded 521.0 mg (91%) of a red oil. 
1H NMR (400 MHz, CDCl3) 
δ 7.85 (d, J = 8.1 Hz, 1H), 7.37 (s, 1H), 7.00 (d, J = 8 Hz 1H), 5.02 (t, J = 7.2Hz, 1H), 4.13 
– 3.99 (m, 2H), 3.83 (q, J = 7.2 Hz, 4H), 2.39 (s, 3H), 1.98-1.79 (m, 2H), 1.78-1.46 (m, 
2H), 1.66 (s, 3H), 1.56 (s, 3H), 1.45-1.19 (m, 2H), 1.36 (t, 3H), 1.27 (t, 3H), 1.16 – 1.02 
(m, 1H), 0.80 (d, J = 6.6 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 149.4, 145.2, 131.5, 
130.7, 126.3, 125.3, 124.6, 118.5, 68.8, 49.5, 42.5, 37.0, 36.0, 29.1, 25.9, 25.5, 21.9, 19.2, 
17.8, 14.7, 11.5; HRMS (m/z) calcd for C21H36N3O3S [M+H]
+ 410.2472, found 410.2475. 
Synthesis of 4.11: 
 
To a round bottom flask containing 804.2 mg (4.427 mmol) L-leucine methyl ester 
HCl salt (prepared according to reference 2), 11.8 mL sat. NaHCO3  and 9.8 mL CH2Cl2 
was added a solution of 944.8 mg (3.162 mmol) TzoCl in 2 mL CH2Cl2 dropwise.  The 
resulting mixture was allowed to stir under N2 at room temperature for 15 h until complete 
consumption of starting material was observed via TLC.  The aqueous layer was then 
separated from the organic layer and extracted with 3x10 mL CH2Cl2.  The combined 
organic layers were dried over Na2SO4, filtered and concentrated in vacuo.  Silica gel 
chromatography (gradient run from 10% EtOAc in hexanes to 20% EtOAc in hexanes) 
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afforded 866.8 mg (49%) of the desired product.  Spectral data matched that previously 
reported in literature.11 
Synthesis of 4.12: 
 
 Started with 350.0 mg (1.208 mmol) TzoCl, 0.15 mL (0.97 mmol) 3-phenyl-1-
butanol, 294.9 mg (2.414 mmol) DMAP and 1.9 mL of CH2Cl2.  Silica gel chromatography 
(gradient run from 8% EtOAc in hexanes to 10% EtOAc in hexanes) afforded 261.5 mg 
(67%) of a red oil. 1H NMR (400 MHz, CDCl3) δ 7.79 (d, J = 8.0 Hz, 1H), 7.39 (s, 1H), 
7.20 (t, J = 7.4 Hz, 2H), 7.14 (d, J = 6.9 Hz, 1H), 7.04 (d, J = 8 Hz, 2H), 6.95 (d, J = 8 Hz, 
1H), 3.99 (dt, J = 9.7, 6.0 Hz, 1H), 3.92 – 3.85 (m, 1H), 3.81 (q, J = 7.2 Hz, 4H), 2.81 (q, 
J = 7.2 Hz, 1H), 2.38 (s, 3H), 1.92 – 1.81 (m, 2H), 1.33 (t, J = 7.3 Hz, 3H), 1.26 (t, J = 7.2 
Hz, 3H), 1.17 (d, J = 6.9 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 149.3, 145.8, 145.2, 
130.6, 128.5, 126.9, 126.3, 126.0, 125.1, 118.4, 68.6, 49.4, 42.4, 37.3, 35.8, 21.9, 21.8, 
14.6, 11.4; HRMS (m/z) calcd for C21H30N3O3S [M+H]
+ 404.2002, found 404.2000. 
Synthesis of 4.13: 
 
Started with 350.0 mg (1.208 mmol) TzoCl, 0.19 mL (0.97 mmol) 3,3-diphenyl-1-
propanol, 294.9 mg (2.414 mmol) DMAP and 1.9 mL of CH2Cl2.  Silica gel 
chromatography (20% DCM and 5% Et2O in hexanes) afforded 307.9 mg (68%) of a red 
oil. 1H NMR (500 MHz, CDCl3) δ 7.76 (d, J = 8.1 Hz, 1H), 7.38 (s, 1H), 7.20 (dd, J = 8.3, 
6.7 Hz, 4H), 7.17 – 7.11 (m, 2H), 7.08 (d, J = 7.5 Hz, 4H), 6.95 (d, J = 7.8 Hz, 1H), 4.05 
– 3.96 (m, 3H), 3.80 (dq, J = 13.9, 7.3 Hz, 4H), 2.40 (s, 3H), 2.34 (dt, J = 7.8, 6.2 Hz, 2H), 
1.33 (t, J = 7.3 Hz, 3H), 1.24 (t, J = 7.2 Hz, 3H);  13C NMR (126 MHz, CDCl3) δ 149.4, 
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145.3, 143.7, 130.8, 128.7, 128.0, 126.6, 126.3, 125.3, 118.6, 68.6, 49.5, 46.9, 42.6, 35.0, 
21.9, 14.7, 11.6; HRMS (m/z) calcd for C26H32N3O3S [M+H]
+ 466.2159, found 466.2156. 
Synthesis of des-methyl-4.14: 
    
Started with 155.0 mg (0.5349 mmol) TzoCl, 90 µL (0.75 mmol) isoamyl amine, 2 
ml sat. NaHCO3 and 2 mL CH2Cl2.  Silica gel chromatography (20% EtOAc in hexanes) 
afforded 169.4 mg (93%) of a yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 8.0 
Hz, 1H), 7.40 (s, 1H), 7.01 (d, J = 8.0 Hz, 1H), 5.52 (t, J = 6.4 Hz, 1H), 3.85 (q, J = 7.0 
Hz, 2H), 3.76 (q, J = 7.2 Hz, 2H), 2.88 (q, J = 7.0 Hz, 2H), 2.38 (s, 3H), 1.68-1.50 (m, 1H), 
1.43-1.17 (m, 8H), 0.82 (d, J = 6.7 Hz, 6H); 13C NMR (101 MHz, CDCl3) δ 147.3, 143.7, 
128.8, 128.8, 125.3, 118.0, 49.8, 42.1, 41.8, 38.3, 25.4, 22.2, 21.5, 14.3, 11.0; HRMS m/z 
calcd for C16H29N4O2S [M+H]
+ 341.2012, found 341.2003. 
Synthesis of 4.14: 
 
To a stirred 0°C solution of 222.6 mg (0.6537 mmol) des-methyl-4.14 in 10 mL 
dry THF was added 17.4 mg (0.727 mmol) 95% sodium hydride.  After 1 hour the reaction 
mixture was removed from the ice bath and placed in an 80°C oil bath.  90 μL (1.5 mmol) 
iodomethane was then added. After 2 hours the reaction mixture was removed from the oil 
bath and allowed to cool.  15 mL H2O was then added at once followed by 15mL CH2Cl2 
and the layers were separated.  The aqueous layer was extracted with an additional 2 x 15 
mL CH2Cl2.  The combined organic layers were dried over Na2SO4, filtered and 
concentrated to yield 283.4 mg crude yellow oil.  Silica gel chromatography (12 g silica 
gel, gradient run from 5% EtOAc in hexanes to 10% EtOAc in hexanes) of the residue 
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afforded 163.8 mg (76%) of a pale yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.78 (d, J = 
8.1 Hz, 1H), 7.27 (s, 1H), 6.98 (d, J = 8.0 Hz, 1H), 3.82 (q, J = 7.2 Hz, 4H), 3.17 (t, J = 8.0 
Hz, 2H), 2.81 (s, 3H), 2.37 (s, 3H), 1.69 – 1.53 (m, 1H), 1.41 (q, J = 7.0 Hz, 2H), 1.32 – 
1.23 (m, 6H), 0.88 (d, J = 6.7 Hz, 6H); 13C NMR (101 MHz, CDCl3) δ 149.3, 143.6, 130.7, 
128.6, 125.2, 119.6, 49.0, 48.5, 41.7, 36.8, 34.5, 25.6, 22.5, 21.5, 14.6, 11.5; HRMS m/z 
calcd for C17H31N4O2S [M+H]
+ 355.2162, found 355.2175. 
Synthesis of des-methyl-4.15: 
 
Started with 155.0 mg (0.5349 mmol) TzoCl, 158.5 mg (0.7501 mmol) 3,3-
diphenylpropylamine, 2 ml sat. NaHCO3 and 2 mL CH2Cl2.  Silica gel chromatography 
(15% EtOAc in hexanes) afforded 192.0 mg (77%) of an off-white residue. 1H NMR (400 
MHz, CDCl3) δ 7.76 (d, J = 8.0 Hz, 1H), 7.39 (s, 1H), 7.26-7.00 (m, 10H), 6.93 (d, J = 8.0 
Hz, 1H), 5.64 (t, J = 6.2 Hz, 1H), 3.97 (t, J = 7.8 Hz, 1H), 3.75 (q, J = 7.3 Hz, 2H), 3.64 
(q, J = 7.3 Hz, 2H), 2.85 (q, J = 6.7 Hz, 2H), 2.31 (s, 3H), 2.20 (q, J = 7.2 Hz, 2H), 1.27 (t, 
J = 7.2 Hz, 3H), 1.20 (t, J = 7.3 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 147.2, 143.8, 
129.1, 128.8, 128.4, 127.6, 126.2, 125.3, 118.0, 49.8, 47.9, 42.2, 41.9, 35.4, 21.5, 14.4, 
11.0; HRMS m/z calcd for C26H32N4NaO2S [M+Na]
+ 487.2144, found 487.2142. 
Synthesis of 4.15: 
 
For procedure see synthesis of 4.14.  Started with 400.0 mg (0.8609 mmol) des-
methyl-4.15, 24.8 mg (1.03 mmol) 95 % sodium hydride, 150 μL (2.07 mmol) 
iodomethane and 18 mL dry THF.  Obtained 410.1 mg (quantitative yield) of a pale yellow 
oil.  1H NMR (400 MHz, CDCl3) δ 7.71 (d, J = 8.1 Hz, 1H), 7.28 – 7.18 (m, 9H), 7.18 – 
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7.10 (m, 2H), 6.93 (d, J = 8.2 Hz, 1H), 3.95 (t, J = 7.8 Hz, 1H), 3.74 (s, 2H), 3.61 (s, 2H), 
3.15 (t, J = 7.5 Hz, 2H), 2.81 (s, 3H), 2.35 (s, 3H), 2.32 – 2.25 (m, 2H), 1.29 (s, 3H), 1.09 
(s, 3H). 13C NMR (126 MHz, CDCl3) δ 149.1, 144.2, 143.6, 130.7, 128.4, 128.4, 127.7, 
126.2, 125.1, 119.3, 48.9, 48.4, 41.5, 34.8, 34.0, 21.5, 14.4, 11.2; HRMS m/z calcd for 
C27H35N4O2S [M+H]
+ 479.2475, found 479.2483. 
Synthesis of 4.16:  
 
Started with 277.4 mg (0.9573 mmol) TzoCl, 200.0 mg (1.340 mmol) N-methyl-3-
phenylpropylamine, 4 ml sat. NaHCO3 and 4 mL CH2Cl2.  Silica gel chromatography 
(100% EtOAc) afforded 368.9 mg (96%) of an orange oil.  1H NMR (500 MHz, CDCl3) δ 
7.79 (d, J = 8.1 Hz, 1H), 7.36 – 7.22 (m, 3H), 7.20 – 7.11 (m, 3H), 6.99 (d, J = 8.1 Hz, 
1H), 3.80 (s, 4H), 3.24 (t, J = 7.2 Hz, 2H), 2.85 (s, 3H), 2.63 (t, J = 8.0 Hz, 2H), 2.38 (s, 
3H), 1.86 (t, J = 7.7 Hz, 2H), 1.34 (s, 3H), 1.23 (s, 3H);  13C NMR (126 MHz, CDCl3) δ 
149.3, 143.8, 141.7, 130.8, 128.5, 128.4, 125.9, 125.3, 119.6, 49.8, 49.1, 41.8, 34.7, 32.9, 
29.7, 21.6, 14.6, 11.5; HRMS (m/z) calcd for C21H31N4O2S [M+H]
+ 403.2162, found 
403.2162. 
Synthesis of 4.17:  
 
Started with 500.0 mg (1.725 mmol) TzoCl, 187.9 mg (1.380 mmol) 3-phenyl-1-
propanol, 337.3 mg (2.761 mmol) DMAP and 3.0 mL CH2Cl2.  Silica gel chromatography 
(gradient run from 5% EtOAc in hexanes to 10% EtOAc in hexanes) afforded 375.5 (70%) 
of a yellow oil. 1H NMR (400 MHz, CDCl3) δ 7.85 (d, J = 8.1 Hz, 1H), 7.39 (s, 1H), 7.26 
– 7.20 (m, 2H), 7.18 – 7.14 (m, 1H), 7.06 (d, J = 6.9 Hz, 2H), 7.00 (d, J = 8.0 Hz, 1H), 
4.06 (t, J = 6.2 Hz, 2H), 3.83 (q, J = 7.6 Hz, 4H), 2.64 (t, J = 7.7 Hz, 2H), 2.41 (s, 3H), 
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2.12 – 1.74 (m, 2H), 1.35 (t, J = 6.9 Hz, 3H), 1.29 (t, J = 7.1 Hz, 3H);  13C NMR (101 MHz, 
CDCl3) δ 149.5, 145.3, 141.0, 130.8, 128.6, 126.2, 126.2, 125.3, 118.6, 69.6, 49.5, 42.5, 
31.8,  30.9,  21.9,  14.7,  11.6;  HRMS  (m/z)   calcd   for   C20H28N3O3S   [M+H]
+   390.1846,  
found 390.1860. 
Synthesis of 4.18:  
 
Started with 100.0 mg (0.3347 mmol) TzoCl, 64.3 mg (0.469 mmol) tyramine, 3 ml 
sat. NaHCO3 and 3 mL CH2Cl2.  Silica gel chromatography (gradient run from 20% EtOAc 
in hexanes to 40% EtOAc in hexanes) afforded 109.3 mg (83%) of a yellow oil.  1H NMR 
(400 MHz, CDCl3) δ 7.81 (d, J = 8.0 Hz, 1H), 7.35 (s, 1H), 7.00 (d, J = 8.0 Hz, 1H), 6.90 
(d, J = 7.9 Hz, 2H), 6.70 (d, J = 7.9 Hz, 2H), 5.83 (br s, 1H), 5.48 (t, J = 6.8 Hz, 1H), 3.75 
(s, 2H), 3.20 (s, 2H), 3.11 (q, J = 6.7 Hz, 2H), 2.70 (t, J = 6.7 Hz, 2H), 2.38 (s, 3H), 1.30 
(s, 3H), 1.06 (s, 3H);  13C NMR (101 MHz, CDCl3) δ 155.0, 147.6, 144.3, 130.0, 129.8, 
129.1, 128.6, 125.5, 118.0, 115.6, 49.9, 44.8, 42.2, 34.9, 21.9, 14.6, 11.1; HRMS (m/z) 
calcd for C19H27N4O3S [M+H]
+ 391.1798, found 391.1783. 
Synthesis of 4.5c: 
 
To a round bottom flask containing a previously degassed solution of 100.1 mg 
(0.2929 mmol) 4.5, 45.8 mg (0.293 mmol) TEMPO, 2.3 mL deionized H2O and 11.7 mL 
CH3NO2 was added 67 µL (0.88 mmol) TFA at once.  The reaction was warmed to 60°C 
and allowed to stir for 1.5 h with monitoring by TLC.  The reaction mixture was then 
concentrated in vacuo and 15 mL EtOAc and 15 mL 1 N HCl were added.  The resulting 
layers were separated and the aqueous layer was washed with 3 x 15 mL EtOAc. The 
combined organic layers were dried over Na2SO4, filtered and concentrated. Silica gel 
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chromatography (gradient run from 20% CH2Cl2 in hexanes to 30% EtOAc  in hexanes) 
afforded 20.9 mg (30%) 4.5c as a colorless oil. 1H NMR (400 MHz, CDCl3): δ 7.79 (d, J 
= 8.0 Hz, 2H), 7.35 (d, J = 7.9 Hz, 2H), 4.79 (br s, 1H), 4.68 (br s, 1H), 4.13 (t, J = 6.8 Hz, 
2H), 2.45 (s, 3H), 2.35 (t, J = 7.0 Hz, 2H), 1.66 (s, 3H); 13C NMR (126 MHz, CDCl3): δ 
144.6, 140.0, 133.1, 129.7, 127.8, 113.0, 68.4, 36.7, 22.2, 21.5; HRMS m/z calcd for 
C12H17O3S [M+H]
+ 241.0893, found 241.0897, and 12.8 mg (18%) of 4.5a. 
Synthesis of 4.16a: 
 
Started with 107.6 mg (0.2929 mmol) 4.16, 19.2 mg (0.0293 mmol) fac-Ir(ppy)3, 
77 µL (0.59 mmol) 48% HBF4, 2 mL deionized H2O and 10 mL CH3NO2.  Irradiated for 
18 h. Silica gel chromatography (gradient run from 100% hexanes to 25% EtOAc in 
hexanes) afforded 34.2 mg (41%) 4.16a as a pale yellow oil 1H NMR (500 MHz, CDCl3): 
δ 7.79 (d, J = 8.2 Hz, 2H), 7.35 (d, J = 8.1 Hz, 2H), 4.24 (t, J = 6.8 Hz, 2H), 2.45 (s, 3H), 
1.97 (t, J = 7.3 Hz, 2H), 1.76 (m, 2H), 1.64 (m, 4H), 1.55 (m, 2H); 13C NMR (126 MHz, 
CDCl3): δ 144.7, 133.0, 129.8, 127.8, 80.5, 68.0, 40.0, 39.7, 23.4, 21.6; HRMS m/z calcd 
for C14H20NaO4S [M+Na]
+ 307.0975, found 307.0974, and 14.6 mg (19%) of an 
inseparable mixture of desaturation and reduced products (4.16c:4.16b = 3.5:1).  Spectral 
data matched that previously reported in literature.11 
Synthesis of 4.17a:  
 
Started with 120.0 mg (0.2929 mmol) 4.17, 19.2 mg (0.0293 mmol) fac-Ir(ppy)3, 
77 µL (0.59 mmol) 48% HBF4, 2 mL deionized H2O and 10 mL CH3NO2.  Irradiated for 
18 h.  Silica gel chromatography (20% EtOAc in hexanes) afforded 30.0 mg (31%) 4.17a 
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as a yellow oil  [∝]D
25 =   -20.8o, c 1.14 (CH2Cl2); 
1H NMR (500 MHz, CDCl3) δ 7.80 (d, J 
= 8.0 Hz, 2H), 7.33 (d, J = 8.0 Hz, 2H), 4.83 (td, J = 10.8, 4.3 Hz, 1H), 2.56 (s, 1H), 2.43 
(s, 3H), 2.20 (d, J = 11.8 Hz, 1H), 1.92 (m, 1H), 1.67 (m, 2H), 1.48 (m, 1H), 1.25 (s, 2H) 
1.20 (s, 3H), 1.16 (s, 3H), 1.05 (qd, J = 13.1, 3.5 Hz, 1H), 0.88 (d, J = 6.5 Hz, 3H);  13C 
NMR (126 MHz, CDCl3) δ 145.0, 134.9, 130.0, 127.6, 84.7, 72.7, 52.3, 42.3, 34.0, 31.7, 
28.9, 27.3, 25.9, 21.8, 21.8; HRMS m/z calcd for C17H26NaO4S [M+Na]
+ 349.1444, found 
349.1446, and 19.9 mg (22%) desaturation product 4.17c as a white solid.  Spectral data 
matched that previously reported in literature.11 
Synthesis of 4.10a: 
 
 
          Started with 112.0 mg (0.2929 mmol) 4.10, 19.2 mg (0.0293 mmol) of fac-Ir(ppy)3, 
77 µL (0.59 mmol) 48% HBF4, 2 mL deionized H2O and 10 mL CH3NO2.  Irradiated for 
18 h.  Silica gel chromatography (gradient run from 10% EtOAc in hexanes to 30% EtOAc 
in hexanes) afforded 19.3 mg (22%) 4.10a as a colorless oil. 1H NMR (500 MHz, CDCl3) 
δ 7.79 (d, J = 8.5 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H), 5.07 (t, J = 7 Hz, 1H), 4.20 (tq, J = 5.5, 
3.0 Hz, 2H), 2.45 (s, 3H), 2.00 (q, J = 7.7 Hz, 2H), 1.85 (q, J = 6.9 Hz, 2H), 1.68 (s, 3H), 
1.59 (s, 3H), 1.48 – 1.42 (m, 3H), 1.16 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 145.0, 
133.2, 132.5, 130.1, 128.1, 124.0, 71.9, 67.6, 42.4, 40.2, 27.1, 25.9, 22.8, 21.9, 17.9; HRMS 
(m/z) calcd for C17H26NaO4S [M+Na]
+ 349.1444, found 349.1443, and 5 mg (6%) of the 
trivial reduction product 15b, a colorless oil. Spectral data matched that previously reported 
in literature.20 
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Synthesis of 4.11a:  
 
Started with 116.7 mg (0.2929 mmol) 4.11, 19.2 mg (0.0293 mmol) fac-Ir(ppy)3, 
77 µL (0.59 mmol) 48% HBF4, 2 mL deionized H2O and 10 mL CH3NO2.  Irradiated for 
18 h. Silica gel chromatography (gradient run from 100% hexanes to 30% EtOAc in 
hexanes) afforded 39.0 mg (47%) of a pale yellow oil.  [∝]D
25 = 59.1o, c 0.915;  1H NMR 
(500 MHz, CDCl3): δ 7.79 (d, J = 8.0 Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 5.32 (br s, 1H), 
4.10 (m, 1H), 2.57 (dd, J = 12.8, 8.7 Hz, 1H), 2.44 (s, 3H), 2.05 (t, J = 12.1 Hz, 1H), 1.47 
(s, 3H), 1.37 (s, 3H); 13C NMR (126 MHz, CDCl3): δ 173.3, 144.1, 136.0, 129.9, 127.2, 
83.4, 52.9, 43.2, 28.8, 26.9, 21.6; HRMS m/z calcd for C13H18NO4S [M+H]
+ 284.0951, 
found 284.0951. 
Synthesis of 4.12a: 
 
 Started with 118.0 mg (0.2929 mmol) 4.12, 19.2 mg (0.0293 mmol) of fac-Ir(ppy)3, 
77 µL (0.59 mmol) 48% HBF4, 2 mL deionized H2O and 10 mL of CH3NO2. Irradiated for 
18 h.  Silica gel chromatography (gradient run from 15% EtOAc in hexanes to 30% EtOAc 
in hexanes) afforded 59.1 mg (63%) of a white solid. 1H NMR (400 MHz, CDCl3) δ 7.68 
(d, J = 8.4 Hz, 2H), 7.35 – 7.18 (m, 7H), 4.10 (dt, J = 10.1, 7.1 Hz, 1H), 3.95 (dt, J = 10.0, 
6.6 Hz, 1H), 2.43 (s, 3H), 2.19 (td, J = 6.9, 1.9 Hz, 2H), 2.06 (s, 1H), 1.53 (s, 3H); 13C 
NMR (101 MHz, CDCl3) δ 146.5, 144.9, 133.0, 130.0, 128.5, 128.0, 127.1, 124.6, 73.6, 
67.7,   42.5,   31.0,   21.8;   HRMS   (m/z)   calcd    for   C17H21O4S    [M+H]
+    321.1155,  
found 321.1154. 
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Synthesis of 4.13a: 
 
          Started with 136.4 mg (0.2929 mmol) 4.13, 19.2 mg (0.0293 mmol) of fac-Ir(ppy)3, 
77 µL (0.59 mmol) 48% HBF4, 2 mL deionized H2O and 10 mL CH3NO2.  Irradiated for 
18 h.  Silica gel chromatography (gradient run from 10% EtOAc in hexanes to 20% 
EtOAc in hexanes) afforded 63.2 mg (56%) of a colorless oil. 1H NMR (400 MHz, 
CDCl3) δ 7.66 (d, J = 7.9 Hz, 2H), 7.34 – 7.16 (m, 12H), 4.08 (t, J = 7.3 Hz, 2H), 2.69 (t, 
J = 7.4 Hz, 2H), 2.42 (s, 3H), 2.39 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 145.9, 144.9, 
133.0, 130.0, 128.5, 128.0, 127.4, 125.8, 77.0, 67.9, 40.7, 21.8; HRMS (m/z) calcd for 
C22H22NaO4S [M+Na]
+ 405.1131, found 405.1125. 
Synthesis of 4.14a: 
 
Started with 102.6 mg (0.2894 mmol) 4.14, 19.2 mg (0.0293 mmol) fac-Ir(ppy)3, 
77 µL (0.59 mmol) 48% HBF4, 2 mL deionized H2O and 10 mL CH3NO2.  Irradiated for 
18 h.  Silica gel chromatography (gradient run from 30% EtOAc in hexanes to 40% EtOAc 
in hexanes) afforded 26.4 mg (34%) of a yellow oil.  1H NMR (400 MHz, CDCl3) δ 7.67 
(d, J = 7.9 Hz, 2H), 7.31 (d, J = 8.0 Hz, 2H), 3.14 (t, J = 7.5 Hz, 2H), 2.72 (s, 3H), 2.42 (s, 
3H), 1.81 (br s, 1H), 1.72 (t, J = 7.5 Hz, 2H), 1.25 (s, 6H); 13C NMR (126 MHz, CDCl3) δ 
143.4, 134.0, 129.7, 127.5, 70.1, 46.5, 40.2, 34.8, 29.5, 21.5; HRMS m/z calcd for 
C13H22NNaO3S [M+H]
+ 272.1315, found 272.1322. 
Synthesis of 4.15a: 
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Started with 140.2 mg (0.2929 mmol) 4.15, 19.2 mg (0.0293 mmol) fac-Ir(ppy)3, 
77 µL (0.59 mmol) 48% HBF4, 2 mL deionized H2O and 10 mL CH3NO2.  Irradiated for 
18 h.  Silica gel chromatography (gradient run from 10% EtOAc in hexanes to 30% EtOAc 
in hexanes) afforded 47.9 mg (41%) of a pale yellow solid.  1H NMR (500 MHz, CDCl3) 
δ 7.58 (d, J = 8.3 Hz, 2H), 7.42 (d,  J = 6.9 Hz, 2H), 7.34 (t, J = 7.8 Hz, 4H), 7.30 – 7.21 
(m, 4H), 3.08 – 3.02 (m, 2H), 2.72 (s, 3H), 2.66 – 2.60 (m, 2H), 2.55 (s, 1H), 2.43 (s, 3H); 
13C NMR (126 MHz, CDCl3) δ 146.2, 143.3, 134.4, 129.6, 128.3, 127.4, 127.1, 125.7, 64.0, 
46.7,  39.9,  35.6,  21.5;   HRMS   m/z   calcd   for   C23H25NNaO3S   [M+Na]
+   418.1447,  
found 418.1439. 
Synthesis of 4.16a: 
 
Started with 120.8 mg (0.3000 mmol) 4.16, 19.6 mg (0.030 mmol) fac-Ir(ppy)3, 79 
µL (0.60 mmol) 48% HBF4, 2 mL deionized H2O and 10 mL CH3NO2.  Irradiated for 18 
h.  Silica gel chromatography (20% EtOAc in hexanes) afforded 53.7 mg (56%) of a yellow 
oil.  1H NMR (500 MHz, CDCl3) δ 7.67 (d, J = 8.1 Hz, 2H), 7.40 – 7.30 (m, 6H), 7.29 – 
7.23 (m, 1H), 4.88 (dd, J = 9.3, 3.9 Hz, 1H), 3.53 – 3.35 (m, 1H), 2.93 – 2.86 (m, 1H), 2.84 
(br s, 1H), 2.76 (s, 3H), 2.43 (s, 3H), 1.95 – 1.83 (m, 2H); 13C NMR (126 MHz, CDCl3) δ 
144.1, 143.6, 134.2, 129.8, 128.6, 127.6, 127.5, 125.8, 70.8, 47.3, 37.0, 35.2, 21.6; HRMS 
m/z calcd for C17H21NNaO3S [M+Na]
+ 342.1134, found 342.1132. 
Synthesis of 4.17a: 
 
Started with 114.1 mg (0.2929 mmol) 22, 19.2 mg (0.0293 mmol) of fac-Ir(ppy)3, 
77 µL (0.59 mmol) 48% HBF4, 2 mL deionized H2O and 10 mL of CH3NO2.  Irradiated 
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for 18 h.  Silica gel chromatography (gradient run from 10% EtOAc in hexanes to 30% 
EtOAc in hexanes) afforded 46.7 mg (52%) of a yellow oil.  Spectral data (1H and 13C 
NMR) matched that previously reported in the literature.21 
Synthesis of 4.18a: 
 
 
Started with 114.4 mg (0.2929 mmol) 4.18, 19.2 mg (0.0293 mmol) fac-Ir(ppy)3, 
77 µL (0.59 mmol) 48% HBF4, 2 mL deionized H2O and 10 mL CH3NO2.  Irradiated for 
18 h.  Silica gel chromatography afforded 50.2 mg (56%) of a yellow oil.  1H NMR (500 
MHz, MeOD) δ 7.68 (d, J = 8.3 Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 7.07 (d, J = 8.5 Hz, 2H), 
6.70 (d, J = 8.5 Hz, 2H), 4.53 (t, J = 6.4 Hz, 1H), 2.98 (d, J = 6.3 Hz, 2H), 2.41 (s, 3H); 
13C NMR (126 MHz, MeOD) δ 158.3, 144.8, 139.1, 134.3, 130.8, 128.6, 128.2, 116.2, 
73.7, 51.5, 21.6; HRMS m/z calcd for C15H16NO3S [M+H]
+ 290.0845, found 290.0845. 
Synthesis of 4.5d:  
 
Started with 100.0 mg (0.2929 mmol) 4.5, 19.2 mg (0.0293 mmol) fac-Ir(ppy)3, 77 
µL (0.59 mmol) 48% HBF4, 2 mL MeOH and 10 mL CH3NO2.  Irradiated for 18 h.  Silica 
gel chromatography (gradient run from 5% EtOAc in hexanes to 10% EtOAc in hexanes) 
afforded 24.5 mg (31%) of a yellow oil.  1H NMR (400 MHz, CDCl3) δ 7.79 (d, J = 8.3 
Hz, 2H), 7.34 (d, J = 8.1 Hz, 2H), 4.13 (t, J = 7.3 Hz, 2H), 3.10 (s, 3H), 2.45 (s, 3H), 1.87 
(t, J = 7.3 Hz, 2H), 1.13 (s, 6H);  13C NMR (101 MHz, CDCl3) δ 144.9, 133.4, 130.0, 128.1, 
73.4, 67.5, 49.4, 38.9, 25.3, 21.8; HRMS m/z calcd for C13H20NaO4S [M+Na]
+ 295.0975, 
found 295.0967. 
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Synthesis of 4.6d:  
 
 
Started with 100.0 mg (0.2721 mmol) 4.6, 17.8 mg (0.0272 mmol) fac-Ir(ppy)3, 71 
µL (0.54 mmol) 48% HBF4, 2 mL MeOH and 10 mL CH3NO2.  Irradiated for 18 h.  Silica 
gel chromatography (gradient run from 5% EtOAc in hexanes to 10% EtOAc in hexanes) 
afforded 20.3 mg (25%) of a yellow oil.  1H NMR (400 MHz, CDCl3) δ 7.79 (d, J = 8.0 
Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 4.10 (t, J = 7.6 Hz, 2H), 3.04 (s, 3H), 2.44 (s, 3H), 1.98 
(t, J = 7.6 Hz, 2H), 1.77 (m, 2H), 1.66 (m, 2H), 1.56 (m, 2H), 1.35 (p, J = 7.3 Hz, 2H);  13C 
NMR (101 MHz, CDCl3) δ 144.9, 133.4, 130.0, 128.1, 85.0, 67.9, 49.6, 36.0, 34.8, 23.6, 
21.8.; HRMS m/z calcd for C15H22NaO4S [M+Na]
+ 321.1131 found 321.1135. 
Synthesis of 4.19: 
 
Procedure similar to that found in reference 17a.  A solution of 82.1 mg (0.2680 
mmol) 4.17a, 6.5 mL 40% methylamine in H2O, and 6.5 mL THF was sealed in a flask 
containing a stir bar.  The mixture was lowered into a 65oC oil bath and stirred for 3 h after 
which it was removed and allowed to cool.  25 mL Et2O was then added followed by 10 
mL sat. NaHCO3 and the layers were separated.  The organic layer was then washed with 
15 mL sat. NaCl, dried over anhydrous K2CO3, filtered, and the solvent was removed in 
vacuo yielding 48.1 mg of a crude yellow oil.  The oil was resuspended in 10 mL Et2O and 
extracted with 3 x 10 mL portions of 1 M HCl.  20% NaOH was then added to the combined 
aqueous layers until the pH reached 13 and the basic solution was extracted with 3 x 10 
mL portions of Et2O.  The combined organic layers were dried over anhydrous Na2SO4, 
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filtered, and the solvent was removed in vacuo to afford 40.8 mg (92%) of a pale yellow 
oil that required no further purification.  Spectral data (1H NMR) matched that previously 
reported in the literature.18a 
Synthesis of (±)-fluoxetine:  
 
 
Procedure similar to that found in reference 17a.  To a stirred 0oC solution of 30.8 
mg (0.186 mmol) 4.19 in 2 mL N,N-dimethylacetamide was added 5.4 mg (0.22 mmol) 
95% sodium hydride and the mixture was allowed to warm to room temperature over 45 
min.  The solution was then placed in a 95oC oil bath and stirred for an additional 30 min.  
60 µL (0.45 mmol) 4-chlorobenzotrifluoride was then added at once and the reaction was 
heated to 105oC.  After 2.5 h the reaction mixture was removed from the oil bath and 
allowed to cool.  10 mL toluene was then added followed by 10 mL H2O and the layers 
were separated.  The aqueous layer was extracted with an additional 2 x 10 mL toluene and 
the combined organic layers were then washed with 10 mL sat. NaHCO3 followed by 10 
mL sat. NaCl.  The solution was then dried over anhydrous Na2SO4, filtered, and the 
solvent removed in vacuo to afford 50.8 mg of a crude orange oil.  The oil was dissolved 
in MeCN (20 mg per 200 µL injection) and HPLC purification (Waters 1525 Binary HPLC 
Pump, 2489 UV/Vis Detector, XBridge Prep C18 5µm 10x100 mm Reverse Phase 
Column, 20 min gradient from 95% H2O/MeCN to 5% H2O/MeCN) yielded 37.8 mg (66%) 
fluoxetine as a colorless oil.  The oil was suspended in Et2O and 0.5 mL 2 M HCl in Et2O 
was added after which the solvent was removed in vacuo to afford fluoxetine hydrochloride 
as a colorless oil.  1H NMR (400 MHz, CDCl3) δ 9.66 (br s, 2H), 7.41 (d, J = 8.3 Hz, 2H), 
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7.37 – 7.21 (m, 5H), 6.89 (d, J = 8.4 Hz, 2H), 5.52 – 5.41 (m, 1H), 3.12 (br s, 2H), 2.62 (s, 
3H), 2.56 – 2.40 (m, 2H).  13C NMR (126 MHz, CDCl3) δ 159.8, 139.2, 129.2, 128.6, 
127.00 (q, JC-F = 3.7 Hz), 125.9, 124.4 (q, JC-F = 271.2 Hz), 123.41 (q, JC-F = 32.8 Hz), 
116.0,  77.1,  46.4,  34.8,  33.4.  HRMS   m/z   calcd   for  C17H19F3NO [M]
+  310.1413, 
found 310.1422. 
4.6.3 Cyclic Voltammetry  
Synthesis of 4.5e in situ: 
 
 
To a stirred 20oC solution of 50.0 mg (0.1464 mmol) triazene 4.5 in 5 mL CH3CN 
(CD3CN was used when obtaining NMR spectrum, page S78) was added 26 μL (0.29 
mmol) triflic acid via gas-tight syringe.  The light pink solution was allowed to stir for 20 
hours in the absence of light. 1H NMR (400 MHz, CD3CN) δ 8.68 (s, 1H), 8.26 (s, 2H), 
4.34 (t, J = 6.6 Hz, 2H), 2.61 (s, 3H), 1.62 (m, 3H), 0.85 (d, J = 6.6 Hz, 6H). 
CV of 0.1 mM of 4.5e in acetonitrile was performed on an AUTOLAB 
PGSTAT302 as a scan rate of 0.1 V/s with Ag/Ag+ reference electrode, Pt counter electrode 
and glassy carbon working electrode.  See Figure 4.4.  Electrodes were mechanically 
polished then cleaned with acetone.  The electrolyte used was tetrabutylammonium 
tetrafluoroborate at 0.1 M concentration.  Observed Eo of 4.5e vs Ag/Ag
+ was -0.42 V (-
.035 V measurement – 0.07 V ferrocene calibration offset).  Ag/Ag+ was converted to SCE 
by adding 0.30 V to the Ag/Ag+ potential.22 
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Figure 4.4 Cyclic Voltammetry of 4.5e 
Eo of 4.5e was found to be -0.12 V vs. SCE. 
4.6.4 18O Labeling Experiment 
To determine the source of oxygen incorporation at the generated hydroxyl 
position, a labeling experiment using 97% 18O water was performed. Standard reactions 
conditions were used with the replacement of HBF4 by TFA and the replacement of H2O 
by H2
18O.  18O incorporation of 90% was estimated based on the relative abundance of the 
peaks at 283.0866 and 281.0776 (Figure 4.5, Mass Spectrum-18O Labeling Experiment).  
A correction was made to account for the peak at 283.0801 in the analysis of 4.5a prepared 
under standard conditions (Mass Spectrum-Standard Conditions).  This experiment 
confirmed our hypothesis that water purposely added to the system was the primary source 
of oxygen for hydroxylation.  The 7% difference between the added 18O labeled water and 
the determined incorporation is likely due to atmospheric water and/or water contained in 
the TFA used in the experiment. 
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Figure 4.5 18O labeling data 
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APPENDIX B: NMR SPECTRA OF COMPOUNDS FOUND IN CHAPTER 1 
Spectral data for compound (R)-hept-6-en-2-ol: 
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Spectral data for compound (R)-oct-7-en-2-ol: 
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Spectral data for compound 1.1, n=1: 
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Spectral data for compound 1.1, n=2: 
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Spectral data for compound 1.1, n=3: 
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Spectral data for compound 1.1, n=4: 
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Spectral data for compound 1.4: 
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Spectral data for compound 1.5: 
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Spectral data for compound 1.2, n=1: 
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Spectral data for compound 1.2, n=2: 
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Spectral data for compound 1.2, n=3: 
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Spectral data for compound 1.2, n=4: 
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Spectral data for compound 1.3, n=1: 
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Spectral data for compound 1.3, n=2: 
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Spectral data for compound 1.3, n=3: 
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Spectral data for compound 1.3, n=4: 
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Spectral data for compound asc-∆C6: 
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Spectral data for compound asc-∆C7: 
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Spectral data for compound asc-∆C8: 
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Spectral data for compound asc-∆C9: 
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Spectral data for compound asc-C6: 
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Spectral data for compound asc-C7: 
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Spectral data for compound asc-C8: 
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Spectral data for compound asc-C9: 
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Spectral data for compound 1.10, n=1:  
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Spectral data for compound 1.10, n=2:  
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Spectral data for compound asc-C4:  
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Spectral data for compound asc-C5:  
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Spectral data for compound asc-C6-MK: 
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Spectral data for compound 1.6: 
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Spectral data for compound IC-asc-C6-MK: 
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Spectral data for compound 1.7: 
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Spectral data for compound 1.8: 
 
 
145 
 
 
Spectral data for compound 1.9: 
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Spectral data for compound IC-asc-∆C9: 
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APPENDIX C: NMR SPECTRA OF COMPOUNDS FOUND IN CHAPTER 3 
Spectral data for compound 3.8: 
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Spectral data for compound 3.8a: 
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Spectral data for compound 3.9: 
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Spectral data for compound 3.11: 
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Spectral data for compound 3.12: 
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Spectral data for compound 3.5a: 
 
 
153 
  
Spectral data for compound 3.12: 
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APPENDIX D: NMR SPECTRA OF COMPOUNDS FOUND IN CHAPTER 4 
Spectral data for compound 4.5:  
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Spectral data for compound 4.10: 
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Spectral data for compound 4.12:  
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Spectral data for compound 4.13:  
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Spectral data for compound des-methyl-4.14: 
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13C NMR (CDCl3) 
Spectral data for compound 4.14: 
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Spectral data for compound des-methyl-4.15: 
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 Spectral data for compound 4.15: 
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Spectral data for compound 4.16:  
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Spectral data for compound 4.17:  
 
 
 
167 
 
Spectral data for compound 4.18:  
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Spectral data for compound 4.5a:  
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Spectral data for compound 4.5c: 
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Spectral data for compound 4.6a: 
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Spectral data for compound 4.7a: 
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Spectral data for compound 4.10a: 
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Spectral data for compound 4.11a: 
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Spectral data for compound 4.12a: 
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Spectral data for compound 4.13a: 
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Spectral data for compound 4.14a: 
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Spectral data for compound 4.15a:  
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Spectral data for compound 4.16a: 
 
 
 
179 
 
Spectral data for compound 4.18a:  
 
 
180 
 
Spectral data for compound 4.5d:  
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Spectral data for compound 4.6d:  
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Spectral data for compound 4.19:  
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Spectral data for fluoxetine: 
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Spectral data for fluoxetine HCl: 
 
 
 
185 
 
Spectral data for compound 4.5e: 
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